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Abstract
Copper as a key component of electron transport chain of eukaryotes is an essential
transition metal ion. . Copper homeostasis in mammals complex and tightly regulated. Its strong
reactivity together with binding with biologically important chemicals can have important
repercussions in human health and overall environment. Tetracycline as one of most abundantly
used antibiotic of the world has become abundant in the environment as well. Herein in this
dissertation we take the journey to explore the complexation of tetracycline with metals in the
environment and the intricate interaction between copper and tetracycline by investigating their
oxidative behavior once they are complexed. We further expand the same goal by investigating
metalloenzyme mimicking peptide and peptoid interaction with copper and their subsequent
activity against catechol oxidation in presence of O2/H2O2 .
In the first project I explored the tetracycline binding with Calcium by using Ytterbium as
a spectroscopic probe through sophisticated paramagnetic Nuclear Magnetic Resonance technique.
My study confirms that Calcium can bind to Tetracycline in several different positions and the
binding follows a specific order depending on the condition. I also investigated the nature and
number of species in solution once tetracycline is complexed with Yb3+. My findings indicate the
presence of at least three different species with Yb3+ and 4 different tautomers of the apotetracycline in the complexed solution in d6-DMSO
In the second project I studied the activities, mechanism and catalytic specificity of the Cu (II)
complexes of TTC and O-TTC towards the oxidation of catechol. The investigation revealed the

xiii

involvement of a dinulear Cu (II) center in the catalysis. We further explored the catechol oxidation
under the influence of H2O2 and found out that both the Cu (II) complexes do exhibit specificity
towards aerobic oxidation at different extent.
The third project covers the activity of copper with tetracycline from an environmental
perspective. In this study we investigated the inhibition activities of Salicylic acid, Benzoic acid
and Bacitracin; a cyclic peptide antibiotic against Cu (II)-TTC catalyzed oxidation of catechol.
Our conclusion based on the experimental data suggests that both salicylic acid and benzoic acid
are weak inhibitors toward Cu(II)-TTC-mediated oxidation of catechol, following a mixed
inhibition pattern while Bacitracin has a strong inhibition profile with a k ic in the low µM region.
All of these inhibitors were picked based on their potential interaction with Cu (II)-Tetracycline
and their availability in the environment.
My last endeavor into this dissertation covers the activity of synthetic enzymes. I present
in this chapter the results about the metal binding capability of a peptide and its oxidation chemistry
with and without H2O2 . Then we compared the results with those of the Cu (II) complexes of a
corresponding peptoid. The study concludes that the peptide binds to Cu (II) as both 1:1, 1:2 metalto-ligand complexes. Both the peptide and peptoid show higher selectivity towards H2O2, with the
peptoid showing much higher selectivity compared to peptide.

xiv

Chapter One: Metalloantibiotics: A Brief Overview
The term” Antibiotic” was first introduced by Selman A.Waksman in 1945 which basically
defined as “produced by microorganisms” with the ability to inhibit and kill other microorganisms;
in Dr. Li-June Ming’s word “ A Microscopic biological warfare”. While a huge number of
antibiotics do not need metals for activity, there are a number of them which requires metals. In
cases of Bacitracin, bleomycin,streptonigrin, and albamycin the metal ions are integral part of the
structure and function of the antibiotics2. In other cases like Tetracyclines (TTC)s, quinolones,
anthracyclines the binding of metal may cause significant chemical and biochemical consequences
which may or may not affect the structure significantly. Just like metalloproteins these special
classes of antibiotics are termed as “Metalloantibiotics”. Compared to non-metal counterparts the
metalloantibiotics are significantly underrepresented in the literature. Their diverse mode of action
ranges from blocking DNA replication and transcription to cell membrane and cell wall synthesis
disruption3. Metalloantibiotics have been present in the environment for thousands of years. The
abundance of environmental metal like copper, iron and massive use of these for non-human
purposes have made these special class of antibiotics almost ubiquitous. Antibiotics like
Bacitracin, Tetracycline have been serving humanity for decades after decades. The natural source
of antibiotics are Bacteria and fungi. As the soil is a major source of Bacteria and fungi their role
in agriculture is significant which affects plant, animal life and overall environment. We picked
one of the oldest of these special class of antibiotics; Tetracycline and explored their critical
interaction with metals, O2/H2O2 and environment in this study. Then we further expanded to

1

synthetic versions of these metal binding molecules and characterized their interaction with
O2/H2O2 .
Introduction to Tetracyclines
Tetracyclines(TTCs) are the one of very first broad-spectrum antimicrobial agents
available having wide range activity against both Gram-positive and Gram-negative bacteria4. The
incredible success of TTCs over course of more than half a century relies on multiple factors like
diverse, convenient and multiple routes of administration, relatively mild side effects , low cost of
production5.

Figure 1.1:Molecular structure of selected tetracycline; Tetracyline(Top),Sarecycline(2RL),Tigacycline(2R-R),Eravacycline(3R-L),Omadacycline(4R-R)

2

The first of the TTCs chlortetracycline (CTTC) was isolated from Streptomyces
aureofaciens in the year of 1948, followed by oxytetracycline (O-TTC) from Streptomyces
rimosus. The flagship compound which is Tetracycline by itself was isolated in 1953 from
Streptomyces aureofaciens, Streptomyces rimosus and Streptomyces viridofaciens6.
With the advent of resistant microorganisms, the clinical use of Tetracyclines for human
use have reduced significantly over the last few decades. As a standard course of action was the
development of newer derivatives for decades after decades like Saracycline, Tigacycline,
Eravacycline, Omadacycline recently. All the four of them were approved between 2018 to 2020.
The molecular structure of selected tetracyclines are presented at Fig.1.1.
Tetracyclines and Metals
The presence of multiple functional groups with electron donating capability such as the
acetamide group at C2 position (Fig 1.2), the phenolic β-diketone moieties located between C10C12 and the C4 position dimethyl ammonium groups renders the structure of TTCs ionizable at
various pH conditions. The obvious ramification of ionization is the different pKa which is denoted
as pKa1, pKa2, pKa3and pKa4

7,8

. The different pKa values of two Tetracycline’s that we cover in

this
Table 1.1. Physicochemical differences between Tetracycline and Oxytetracycline with their
usage
Compound

Human

Animals

3.2;7.6;9.6,12

+

+

Oxytetracycline 3.53;7.25;9.58

+

+

Tetracycline

pKa values

Percent
References
absorption(GIT)
Agwuh and
MacGowan,
60-70
2006, Garrett,
1963
60-80
Şanli et al., 2009

Elaboration; GIT: Gastrointestinal tract; +: used; -: not used.

3

work is listed in Table 1.1. The metals serve the purpose of stabilizing these electron rich
functional groups.
Highly polarizing transitional metals with positive charges partially share their positive
charge with the negative charges of the electron donor atoms. The resulting electron delocalizing
of the sharing atom creates the chelating ring which in turn stabilizes the big electron density of
TTCs

9,10

. Despite the development of huge array of new generation derivatives of Tetracycline

the basic structural need for antibacterial activity has remained similar. The new generation of
TTCs development basically hovers around substituting, adding different functional groups which
renders these derivatives to be more soluble in different body compartments (like chlortetracycline,
oxytetracycline, methacycline) or more lipophilic (like doxycycline). Therefore all the TTCs tend
to form metal complexes with transitional metals. Despite there is lack of consensus on the site of
specific metal coordination; elaborate exploration tends to indicate the binding is limited to several
sites which are the oxygen at the B,C,D rings and the coordination of nitrogen atom at the
dimethylamino group at location C4 with oxygen(-OH) at either at C3 or C12a. The specific
preference for binding site depends on several factors including favorable electron transition,
metallic ion radius size and the overall stability of the chelating ring 11.

Figure 1.2.Tetracycline
2: Tetracycline basic
basicstructure
structure with numbering scheme

4

Figure 1.3.Tetracycline (Zwitterion)12

Figure 1.4.Tetracycline Extended structure1

Figure 1.5.Tetracycline Twisted structure1
5

Table 1.2 presents the ionic radius and electronegativity of different metal ions associated
with formation of complexes with TTCs. From the table it is evident that electronegativity and
radius of the metal might be playing a vital role in selecting specific binding sites in TTCs.
Metal ions with radius within the range of 0.55-0.86 Å binds with preferentially at the C2
and C3 positions. With ionic radii less than 0.7 Å this preference switches to C10-C12 position.
Comparing the set of data this limitation of size preference is site specific which is less than 0.55
Å for C2 and C3 site and less than 0.7 Å at C10-C12 site. Ions larger than 0.86Å might not fit at
the C2 and C3 site while too small radii also cannot create enough strain to sustain bonding with
TTC4, 12
Table 1.2: Ionic radius of different metals in Tetracycline binding sites11, 13-22
High
Binding

Ionic

Metal ion

concentration

Electronegativity(mV)

site(1:1)

radius(Å)
Binding(>1)

Cu2+

C2-C3

C2-C3,C10-C12

0.62

1.9

Mg2+

C2-C3

C2-C3,C10-C12

0.76

1.31

Ca2+

C10-C12

C11-C12,N4-O3

1.12

1

Fe2+

C2-C3

C2-C3

0.78

1.83

Co2+

C2-C3

C2-C3,C10-C12

0.74

1.88

Ni2+

C10-C12

-

0.715

1.91

The changes of pH of the system TTCs in affects the equilibrium between protonated and
deprotonated species of TTCs. The resulting conformational changes at different pH have been
studied and reported 1, 23. The difference between twisted and extended conformation seems to be
controlled by the C4-Dimethylammonium group’s protonation states and H-bonding / repulsion
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with OH12a. The resulting H-bonding between OH12a and C4-Dimethylammonium forces the
extended conformation at basic pH while the repulsion between them gives rise to twisted state at
acidic or neutral pH4. These dynamic changes of solvent environment with changes of H+
concentration controls the binding position of metals and efficiency11. Moreover variation in
ionization enthalpies of the buffers and polarity of the solution containing organic solvents and
metals affects the deprotonation TTC’s and thus complexation

14,17, 24

. Our study for binding

mostly uses DMSO , considering the lack of data of complexation in DMSO and relative ease of
assignment of peaks without unpredictable variations in protic environment..
The metallic binding also results in further conformational change. The Ca2+ binding at
C10-C12 moiety results in deprotonation of Dimethyl ammonium group at C4 which eventually
flips the complexed TTC conformation to extended form from twisted form. The Mg2+ binding on
the other hand at N4 and C3-O stabilizes the twisted conformation. Even the TTC complexed with
Cu2+ and Mg2+ at A ring inhibits further binding with other metals ( Ca2+ and Mn2+) due to
conformational changes25. So far from the literature search it was almost impossible to come to
consensus about the stoichiometric ratios and stability constants with different metal ions. Table1.
2 is an attempt to give a tentative summary. The number of possible tautomers in different
environmental condition probably have contributed to this lack of consensus26. As metals are
essentially acting Lewis acids or electron pair acceptors they also impart acidity to solution. It
turns out that at molar ratio of 1:1 with pH range between 7.5 to 11 the net charge of the Ca2+-TTC
complex doesn’t change, which is reverse for Mg2+-TTC complexes as in this case both the molar
ratio and net charge changes with pH13.The study also found out that the oxytetracycline(OTTC)
has no proton left after complexing with Ca2+ and Mg2+ 27.The speciation order is also investigated
in this study which indicates 1:2,1:1,2:1 metal to ligand complex with low, middle and high level
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of metals present in the solution. It is interesting that the stability of Metal-TTC complex do not
follow the change of increasing net charge suggesting domination of covalent bonds in metal-TTC
complexes. All these studies encompass either aqueous or pH controlled environment where the
H+ concentration does play a significant role in binding and speciation. In this study we tried to
shed light on binding study in non-aqueous environment with both Ca2+ and Yb3+.
Tetracycline Mode of Action and Metals:
TTCs inhibit bacterial growth by reversibly inhibiting the attachment of tRNA( aminoacyl)
to the 30s ribosomal subunit. As we discussed earlier the tetra rings are a must in TTC structure
while structural features like dimethyl amino group at C4, α- stereochemistry at C4a and C12a, βketoenol at C10-12 are critical for retaining antibacterial activity6. Majority of the various
derivatives of TTC are basically substitutions in the C7-C9 position with largely hydrophobic
groups like hydroxyl,methylene and methyl groups. The TTCs entry into cells also varies with the
type of bacteria. With Gram positive and gram negative bacteria having different cell wall structure
TTC permeability is significantly different1, 28. The 20-80 nm multilayered thick peptidoglycan
cell wall of gram-positive bacteria is way different than roughly 10 nm thick gram-negative
bacterial cell membrane where a thin peptidoglycan layer is surrounded by outer membrane. In
case of gram-negative bacteria the cationic Metallo-Tetracycline complexes accumulate at the
periplasmic space due to the Donnan potential across the cell membrane. When the periplasmic
space is relatively aqueous the Metallo-Tetracycline complexes most possibly dissociate into free
TTCs which later diffuses through the inner layer of periplasmic space of gram-negative bacteria29,
30

. On the other hand the gram-positive bacteria is thick walled where both the free and complexed

form of tetracycline is assumed to cross cytoplasmic membrane in energy dependent fashion which
is driven by primarily ∆pH dependent proton motive force30,
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31

. Both the pH and metallic

concentration inside the cell is higher which makes us assume that TTCs possibly exist as an
equilibrium between the free TTCs and complexed forms/form. This assumption lead to the idea
that the TTC molecule that binds to the ribosome is possibly a complexed form thus MetalloTettracycline32, 33.
Metallo-tetracylcines and Resistance:
The metallo-tetracycline complexes and tetracycline by itself show significant change of solubility
profiles; absorption, distribution in different body compartments and antimicrobial properties34.
These alteration of physico-chemical properties make marked difference in the permeability of
these complexes to microorganisms35, 36.The reported efflux of TTCs from inside the cell has been
linked to to permeability of Metal-tetracycline complexes across the cell membrane. But at present
the influence of Metal-Tetracycline on resistance development is poorly understood due to scarce
research. In case of TTCs the resistance was never linked to the mutations at the ribosomes where
the TTCs bind. The reason for resistance is mostly directed towards lack of accurate binding site
or multiple binding sites. A careful investigation of mechanism of antibiotic action due to structural
changes may shed lights on resistance in detail.
Tetracyclines and Tet-R:
Metal complexes with tetracycline plays significant role in microbial resistance development
which is some cases concentration dependent. Studies show the binding of tRNA to mRNA of the
70s ribosome is assisted by by Mg2+ concentration in the millmolar quantity at either P site or P
and A site

37

. Stable complexes with Mg2+ may enhance TTC attack on ribosomes resulting in

improved inhibition of protein synthesis 38, 39. A membrane associated protein TetA is responsible
for the active efflux of TTC from inside of the cell in order to prevent intracellular concentration
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of TTC to reach a certain critical concentration. On the other hand TetR controls the expression of
certain genes( tet A, tetR )which are vital for the expression of proteins such as TetA and TetR.
Binding of TetR with TTC only fails to induce any conformational change which is required for
the expression of resistant genes which is tetA and tetR. The [Mg-TTC] 2+ complex on the other
hand is able to induce the conformational change upon binding with TetR which in turn results in
the expression of resistant genes 40, 41. The series of conformational change induced by the binding
of [Mg-TTC] 2+ complex with TetR is indispensable for the expression of resistant genes[ ]. The
octahedral coordination of Mg2+ ion around the TTC is specifically responsible for the induction
of conformational change in TetR . Without the coordination of Mg2+ with TTC this crucial
induction of conformational change is not possible

42, 43

. Advanced kinetic and thermodynamic

study of [Mg-TTC] 2+ and free TTC complexes with TetR further solidifies the claim[ ] and
furthermore suggests even if the TTCs bind to TetR at low enthalpy states it still fails to induce
conformational changes which is essential for the relaxation of protein

44

. Several studies also

demonstrated the binding amino acids like tryptophan, cysteine, histidine ,leucine ,glycine through
both metal bridge and H-bonding 42, 45. The same study is also done Cu2+ and resulted in the same
conclusion46 which is Cu2+ is required. The integrity of Ring A and 10, 11, 12 position is absolutely
essential for both Mg2+ coordination with TTC and subsequent induced conformational change 42,
43

. The conformational inducing property is also influenced by pH which regulates the protonation

and deprotonation of OH- groups at 10, 11 position at acidic pH (3-5) and the N-4 , O-10H at basic
pH(7-8)

42, 43

. All these studies so far confirms that the resistance of TTCs are closely related to

the formation of Metal complexes which is also highly likely for the new generation TTCs as the
core structure so far has remained somewhat unchanged. The existence or abundance of
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transitional metals in the environment and their interaction with TTCs are triggering selective
pressure on the microorganisms to develop resistance by mutations .
Tetracycline Absorption in Bacteria and Metals:
TTC absorption through bacterial cell membrane is distinctive for gram positive and gram
negative bacteria. In case of gram positive bacteria TTCs and Metal-TTC complexes diffuse either
actively or passively through the porin channels and then eventually dissociates into free TTCs
and metals inside the periplasmic space of lipid bilayers while for the gram negative bacteria TTCs
diffuse across the cell membrane as a result of Donnan potential47, 48,49. Several studies suggest
there are no uptake of TTCs without the presence of metals , which is consistent with the previous
study of no conformational change without the presence of metals in case of TetR 42, 43. However
the study was done with E.coli with inverted membrane vesicles. The study needs more diverse
model organisms to be sure about the conclusion. Our understanding so far divalent metals
somewhat stimulates the uptake of TTCs and this stimulation follows certain order with different
Metals like Co2+>Mn2+>Mg2+>Cd2+>Ca2+

49

. The trend exactly reverses while we order the

dissociation constants of Metal chelates . Co2+-TTC complex is 2-2.5 times more absorptive than
Mg2+ chelate while no absorption was reported in the absence of Co2+ 49.All these data reiterates
the importance of metals in the development of TTC resistance and pH playing a huge role in this
whole process. At pH close to 7 the zwitterionic TTCs are the most permeable species to E.coli
and metal-cation complex is not a requirement for this uptake

50

. Our study is mostly done in pH

7.35 for this reason, keeping the zwitterionic form our focus. The binding study however has been
conducted mostly in DMSO due to lack of binding research in DMSO.
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Reversing Bacterial Resistance through Metals:
There has been works on using metals to reverse the resistance. Metal coordinated TTCs
have shown enhanced clinical usefulness. TetA transports TTCs coordinated through C11 and C12
oxygen, a group hypothesized that if an inert metal complex could be synthesized which is
coordinated through Ring A of TTC could potentially bypass the efflux mechanism

51, 52

.

Synthesized [Pt(TTC)Cl2] is found to be six times more effective against resistant E.Coli. This
same group also investigated palladium(II) complexes of TTCs and they also showed increased
activity.
Tetracycline and Non-Human uses
Antibiotics are one the biggest group of pharmaceuticals being used and TTCs specifically
are the second largest group of antibiotics being used36, 53. The surge of TTCs in disease prevention
and growth promotion in animals is alarming in recent years54. The enormous use of TTCs in
animal feed way exceeds the usage for human uses and puts TTCs first in this kinds55.The reduced
use of TTCs in human disease treatment is largely because of widespread emergence of antibiotic
resistance56. Global surge of resistance has reached an unprecedented level in recent years which
constitutes problems both in the health and environmental front. The awareness and strictly
controlled usage of antibiotics is a call of the time to control this unprecedented surge of resistance
.TTCs that are being used to treat humans have contributed relatively low compared to used in
animals for emergence of resistant gene development4. The massive use of TTCs in growth
promotion and prophylactic purposes might have contributed the most in developing resistant gene
and subsequent transfer. The fact that major fractions of unabsorbed TTCs from various living
organisms were either expelled by urine or fecal matter .This fraction hovers around staggering
35%-90%57. The concentration TTCs found in wastewater, soil samples and animal waste ranges
12

from ng/L to mg/L which is huge58. Despite these levels of TTCs in the environment do not exert
toxic effect on humans, the high exposure of TTCs in the environment in low concentration do
exert temporary selective pressure on the microorganisms. There are studies that indicate exposure
of low concentration of antibiotics for extended period of time eventually results in development
and sustenance of TTC resistance5, 59, 60.
Metallo-tetracyclines and Environmental Interaction with Secondary Metabolites:
The massive presence of tetracycline in the environment pose a huge risk to the
environment given its propensity to bind scores of divalent metals. The chemical structure of TTCs
are perfectly suitable for binding all kinds secondary metabolites present in the soil and overall
environment as well; which have been discussed in-detail in previous sections. The abundant
organic molecules with O and N functional groups in the environment , charged groups like
carboxylates, amino groups or polar groups like carbonyl or hydroxyl groups can interact with
TTC through cation bridging or exchange, surface complexation mechanisms 18, 61. Majority of the
environmental studies are somewhat focused on removal of antibiotics and toxicological studies
which focus on a narrow spectrum due to the massive resources required to diverge into broader
research

62, 63, 64

.Once TTCs bind to these organic molecules the adsorptive interactions are

enhanced by metal bridging in a lot of cases which results in formation of ternary complexes. The
strength of these bindings depend on the stability constant of metal bindings and the parotic
environment (pH).( Wang 15, 16, 65-68.The stability of TTC metal complexes are usually high in basic
environment but enhanced cation exchange decrease the bindings through cation bridging

69, 70

.

At pH above 6 the zwitterionic form of TTCs have higher tendencies to form ternary complexes
which is our studies standard pH. The Benzoic acid, Salicylic acids and Bacitracin interaction
with Cu(II)-TTC investigation in this study aims for this ternary complex formation and eventual
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inhibition pattern recognition which will cover the interaction of metallo-Tetracyclines with
organic molecules present in the environment that is quite often over looked in current research.
Copper in Biological Systems:
our choice of transitional metal Cu(II) has been ubiquitous in the Metal-bimolecular
binding studies. Copper’s role in diseases and biological systems have been discussed subsequent
chapters. The very efficient electron transfer ability of Cu1+ to Cu2+( Standard reduction potential
of 0.4 vs 0.339 of H2O) ( noble metal)makes it a part of the active sites of many proteins to assist
a myriad of biological redox functions.
The different copper containing enzymes have been discussed in later chapters. The
relatively low concertation of Copper in human body (highest concentration in liver (3.47±1.510)
mg/g and brain (3.32±1.51) mg/g) 71 should not confuse us about the importance. The preferential
binding motifs for copper in our system depends heavily on the oxidation state and electronic
charge distribution of the associated ligands. With a 3d9 paramagnetic electron valence the most
common oxidation sates of copper are either +1 or +2.
The preferred geometry for Cu (II) coordination compound is mostly octahedral. The Cu3+
is however never reported in biological media. The oxidized (Cu (II)) and reduced (Cu (I)) however
prefers different residues for binding. The reduced copper tends to bind with sulfur rich compounds
like cysteine and methionine while the oxidized Cu (II) prefers O and N containing moieties.
The charge state however changes the Metal-Metal distance with the reported protein
crystal structures. The reduced states of copper containing proteins have longer interatomic
distance between coppers. The different kind of Copper proteins have been discussed in later
chapters.
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Conclusion:
As we gorged in the all the information about TTCs , it is evident that metallo-biomolecules
and metals have roles in humans and environment that is undeniable.With our short introduction
we introduced the our molecules of interest TTC’s and metals(Yb3+, Cu2+ ). In our later chapters
we followed this through with our 3 different investigations.
Our study started with characterizing the metallic binding of TTC(Yb3+, Ca2+), then moved on to
its interaction with O2/H2O2 once it binds with metals( in our case we picked Cu(II) ). Once we
stablished the interaction is there and figured out its pathway; in our third study we ventured on to
see how the organic molecules abundantly found in the environment interact with it (inhibition
study with Benzoic acid, salicylic acid and Bacitracin). In our last study we synthesized moieties
(peptides & peptoids) with metallic binding pockets and investigated their O2/H2O2 interaction.
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Chapter Two: 2D 1H NMR Study of Paramagnetic Ytterbium (III)-Tetracycline Complex
Background:
The discussion from the first chapter covered about the transition metal binding of TTC. It
is evident that TTC requires the zwitterionic form to be able to enter cells3, 4. Once inside the cell
the concentration gradient of metals (e.g. Mg2+) inside cell drives the bidentate binding through
the 11,12-ketoenol moiety which upon formation of the complex binds to 30S ribosomal subunit
and subsequently disrupts the interaction between tRNA and mRNA leading to inhibition of
protein synthesis5. The binding however gets triggered when the concentration of Mg2+ is between
1-4 mM5. The highest concentration of any mineral in human body is calcium ( Ca2+). Calcium
accounts for almost 1-2 percentage of an adult human body weight 6. Over 99% of calcium of
human body is available in the bones as hydroxyapatite ( HA)(Ca10 (PO4)6 (OH) 2). This particular
form of calcium with phosphate provides skeletal structure of humans and provides as a reservoir
for calcium for the body 7. In blood plasma calcium exists in three different forms complexed or
chelated form which accounts for about 9% of the serum calcium basically acts as the reservoir
which allows it to travel to different parts of the body and get absorbed.
The primary chelated forms are phosphates(HA), carbonate and oxalates. 40% of the
calcium however is bound to proteins ad cannot be used by the tissues. In the serum albumin and
globulin are the primary calcium bound protein whereas in the cells calmodulin plays the
regulatory role. The concentration calcium that often reported in the literature as 8.8 to 10.4 mg/dL
is actually the free ionized calcium which constitutes about 51% of the total concentration. Any
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concentration above this in the blood serum is considered as toxicity8 ,9. However this massive
deposit of calcium is tightly regulated in the blood plasma 10.
Tetracycline derivatives are bacteriostatic in nature means they control the proliferation
bacterial load in the system and thus there is specific concentration in the serum needs to be in a
specific range - 0.5 to 1.5 µg/ml 11. As discussed earlier the high affinity of TTC derivatives to
form complexes with transition metals like Fe(II), Fe(III),Cu(II), Mg(II), Ca(II) makes it a
challenge from the bioavailability perspective.
All these complexes are somewhat poorly absorbable from GI tract. It has been a common
knowledge for more than half a century that milk and dairy products, antacids and any food
containing polyvalent cations can interfere with the absorption of TTC from 50 to 90% and is
generally recommended to avoid while taking TTC medication11.
Our study also confirms this complexation with Ca2+ . The reported coordination site for
this complexation has been reported as at 1:1 stoichiometry C10-C12 site and at higher
stoichiometry C11-C12,N4-O3 12, 13 14, 15.
All these studies however are reporting the coordination sites either UV-spectroscopic data
or circular dichroism (CD) without possible structural information based on speciation. TTC can
have scores of different tautomers( Figure 2.1) based on pH condition or solution type 16.
We tried to investigate this matter using Yb3+ as a probe using 1H NMR paramagnetic
NMR and conventional UV-Vis spectroscopy. Lanthanide ions based on their electronic
configuration, size and spectroscopic properties are often used a surrogates of Ca2+ ion to study
biological interactions2.

26

Although Ln3+ ions binds ligands much less covalently than does the Ca2+, Fe3+ or other
transition metals they have been used successfully against these metals before2, 17

Figure 2.1. Major ionization states of
Tetracycline at different pH 2
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Table 2.1 Ionic radii of Yb3+ 18
Ion

Yb

Coordination

Crystal Radius

Ionic Radius

VI

1.008

0.868

VII

1.065

0.925

VIII

1.125

0.985

IX

1.182

1.042

3+

Yb3+ , is considered a handy tool for the study of drug systems like TTC because of their magnetic
and chemical properties 19, 20, 21. The paramagnetic nature along with spin-orbital coupling (i.e. J =
1/2−15/2) of some Ln3+ ions allows us to investigate the structure of drug complexes by tools like
NMR where the standard 1H NMR signals of these bound complexes are paramagnetically shifted
because of the use of Ln3+ 22 ,23. Alkaline earth metals are well known for their affinity towards
oxygen rich moieties and can bind to β-ketophenolate moiety of TTC. Ln3+, our case the Yb3+
should theoretically bind to the same. The ionic radii of Yb3+( 1.14 Å vs 1.065 for Ca2+in crystal
24

, Lewis acidity and prefers oxygen rich environment all suggests that a thorough study of Yb3+

complex could very well shed light on the TTC complex of Ca2+. In our research group we have
employed lanthanides as spectroscopic probes for the study of Metal-antibiotic, protein
interactions for years 25-27 due to their preferable spectroscopic and magnetic properties. Ln3+
have been used as surrogates for the alkaline earth metals which also served as a non-redox active
metal substitute in these studies28. In case of TTC the presence of different species, stoichiometry
and binding mode is still somewhat vague. With the use of Yb3+ we took this journey to investigate
these. We discuss here the study of tetracycline and determine the structure of Yb3+-tetracycline
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complex by the use of optical and 2D 1H NMR technique (EXSY) which essentially gives us the
tools for further studies of interaction of metal tetracycline complexes with biomolecules.
Paramagnetic 1H NMR and 2D 1H NMR (EXSY) are useful tool for the
investigation of Metal-ligand binding. Paramagnetic nuclei like Yb3+ can cause isotopic shifts in
the 1H NMR signals which results in far shifted signals compared to standard 1H NMR signals
which usually stays within 1-18 ppm . The technique has its fallacies being less sensitive than the
conventional 1H NMR but the pulse sequence can be optimized for the fast relaxing protons near
the metal center. Some paramagnetic models like Cu2+ are bit challenging because of their very
broad signals which are usually very far up or down the transmitter pulse. These signals are very
hard to resolve. Here the use of Yb3+ comes in very handy given their similar binding properties
and bond distances
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. With Yb3+these signals tend to be relatively sharp and within reasonable

spectral window for excitation

29, 30

. Ideally EXSY pulse sequence can be utilized to correlate

isotopically shifted signals to their well resolved diamagnetic counterpart’s by taking advantage
of the fact that there are usually fast exchange of the binding equilibrium. A typical EXSY pulse
sequence is pretty much an optimized NOESY by manipulating short recycle times and standard
mixing time of ~1-30 ms 30, 31 , 31.
So the use of 2D 1H NMR technique facilitates the assignment of proton signals of these
Ln3+-drug complexes and determine their configuration in solution which in our model system of
tetracycline complex was not done previously. On the basis of optical and NMR studies we
conclude that four different Yb3+-tetracycline complexes with the metal to ligand ration of 1:1,
2:1, 3:1 and 2:2 are formed in solution under different metal ion concentrations. These complexes
are under slow chemical exchange with each other in the solution. With the help of 2D 1H NMR
(EXSY) technique a complete 1:1 Yb3+-tetracycline complex signal assignment of the shifted
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signals were made. The coordination of the Yb3+-tetracycline complex matches with the reported
coordination data of Ca2+-tetracycline complexes. 12 .

Results and Discussion:

Figure 2.2:36-deoxy-6-demethyltetracycline- Minimum
structure for retaining antibiotic activity 1
Optical Studies:
Literature reports on TTC binding with transitional metal studies is extensive and conclusive. The
carbonylamide ring (A ring) (Figure 2.2) in TTC contributes to the absorption band 250-300 nm
and the BCD ring which is quite often referred as phenolic-diketone ring contributes to the 250300 and 340-380 nm absorption 32.The X-ray crystallographic data of Co2+ binding of TTC is
already reported and the Co2+is reported to coordinate at C11 and C12 oxygen moiety (Figure 2.2).
Our starting optical study with Cobalt titration into TTC confirmed just that. The 250-300 nm peak
as we can see in figure 2.4 is the least affected while there is clear isosbestic point at 365 nm
suggesting BCD ring is the binding motif. Just like it optical data of Ca2+ binding at BCD ring is
available in the literature suggesting binding at C10-C11 site

. The X-ray crystallographic data
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of Co2+ binding of TTC is already reported and the Co2+is reported to coordinate at C11 and C12
oxygen moiety (Figure 2.2).

30

Figure 2.3. Tet repressor class D complexed with Co2+ and tetracycline- 2VKE
(Palm et al., 2008)

Figure2.4.- Structure of the Tet Repressor-Tetracycline Complex with Mg2+
(
(Hinrichs et al., 1994)
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Cobalt titration into TTC confirmed just that. The 250-300 nm peak as we can see in figure 2.4 is

Figure 2.5.Co (II) titration into tetracycline in pH 7.35(50:50 100mM MeOH:
HEPES) and absorbance as a function of Co(II): tetracycline(TTC) molar ratio
at 406 nm( inset)

the least affected while there is clear isosbestic point at 365 nm suggesting BCD ring is the binding
motif. Just like it optical data of Ca2+ binding at BCD ring is available in the literature suggesting
binding at C10-C11 site

.

33

Nuclear Magnetic Resonance Study of Ca2+ Binding to Tetracycline:
We took a different approach here, instead of UV-Vis spectroscopy we designed an
experiment where we titrated 16 equivalent Ca2+ into 1 mM of TTC in d6-DMSO to see how much
metal is needed to see clear binding. From the Figure 2.5 it was obvious that upon titrating 12
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equivalents of Ca2+ the 12-OH signal is the first signal to disappear while we still have the amide
signal at 9.5ppm and 9.1 ppm and 10-OH signal gradually shifting up field; decreasing in intensity
suggesting the first

10-OH

C2NH2
3-OH

12-OH

Figure 2.6: titration Ca 2+ into 1 mm of TTC; The top spectra is with 16 Eq.of Ca2+,
bottom spectra is the TTC (1 mM)

Ca2+ probably binds at the O at C12 position coordinating with C1 carbonyl moiety. The C12a
signal at 10.2 ppm rapidly shifting up field, reducing intensity but not disappearing confirms the
possible coordination of Ca2+ at C12-C1. While the amide at C2 is significantly affected even at 1
equivalence of Ca2+. This rapid change in intensity suggests the second Ca2+ binds possibly at C2;
N-O

amide

position. . The third Ca2+ binds at the C10 position while coordinating with the O11.

.however literature reports so far suggests that the first binding at C11-C12 32. The study however
was done with a pH of 7.4 while I did the study completely in d6-DMSO although the massive
water signal at 3.3 ppm suggest copious amount of water in the solution. The CaCl2 is very
hygroscopic which picks up moisture rapidly from the environment. Our finding for the second
binding site matches with the reported literature. Which is C2 amide carbonyl with the C3-O. The
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C3-OH signal at 7.4 disappears after > 12 equivalents of Ca2+ . The last probable Ca2+. binding at
C10-C11 is almost obvious as this is the site with potential binding left after the first two events
of binding. Thus we have concluded our binding study with a difference from the reported sites of
binding; which could be attributed to various ionization states of TTC at different pH especially
the study being conducted at pH 7.4. At this pH the TTC is zwitterionic in nature. However, with
the spectral change it is not clear to which site Ca2+ binds at what order. We do have an idea about
the binding sites which are O at C12 position coordinating with C1 carbonyl moiety, C2- N-O amide
position, C10 position coordinating with the O11. Further study is required to confirm the order
and the speciation.

Figure. 2.7. Yb (III) titration into Tetracycline at pH 7.35 (50:50; 100 mM HEPES: MeOH)

Figure 2.8. Absorbance as a function of Yb(III)-Tetracycline(TTC) at 402 nm in 1:1
MeOH:HEPES( 50 mM)
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Optical Studies of Yb3+ Binding to Tetracycline: The formation of Yb3+- TTC complex in
50:50 MeOH;HEPES( 50 mM) can be monitored by the use of UV-Vis spectroscopy and is
presented at Figures 2.6 an 2.7 . Stoichiometric amounts of Yb3+ was titrated into TTC gradually
in a buffered 1:1 MeOH:HEPES( 50 mM) solution and their absorbance against equivalent of Yb3+
plotted in figure 2.7. Figure 2.6 shows the formation of Yb3+- TTC complex in HEPES buffer at
7.35 pH.. From figure 2.6 it is evident that there is formation of the Yb3+- TTC complex. The three

Figure 2.9: Optical Job Plot(Absorbance vs
[TTC]/([Yb(III)]+([TTC]) (50:50 MeOH:HEPES)
isosbestic points at 280 nm, 310 nm and 370 nm clearly indicates the presence of equilibrium
between two species while the formation of 4th isosbestic point at the top of the peak at 390 nm
suggests there is probably the third equilibrium . The optical job plot at 2.8 suggests that there is
the formation of bi or tri-nuclear Yb3+- TTC complexes.in this buffer system. We however could
not see clear formation of Yb3+- TTC complexes in just DMSO. The optical spectra also suggest
the binding is happening at both A and BCD ring systems; suggesting probable multiple
Yb3+binding to the TTC. Our plot at 2.7 suggests the binding of more than 1 Yb3+with TTC. Our
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study so far suggested that TTC behaves like a bivalent dianion which after losing enough protons
in a buffered environment in the zwitterion state form complexes with Yb3+. The bi or tri-nuclear
system, each Yb3+is bound with the two oxygen of the ligand. From the optical study alone we can
conclude that the binding is concentration and pH dependent. With appropriate pH environment
the Yb3+ binds in multiple positions in stoichiometries of 1:1, 2:1and possibly 1:3, Metal to ligand
ratio which is consistent with reported bindings of lanthanides with TTC. 2.
1H

NMR and 2D EXSY Studies of Yb3+ Binding to Tetracycline:

Yb3+ ion has been used as a probe in this study because the optical study confirmed
equilibrium among more than two different species over the course of 2.5 equivalents of Yb3+
titration and the large magnetic moment, fast relaxation rates which are very promising for
paramagnetic NMR study. Our Job plot (Figure 2.8) suggested formation of bi/tri-nuclear
complexes together with the titration data from Figure 2.7 and 2.8 we primarily assumed Yb3+binds
to TTC with more than 1 equivalents. Even though the experiments of Figure 2.6-2.8 were done
in buffer systems with pH of 7.35, our study with different pH (10) revealed the same trend.
So naturally we went on to do a titration of Yb3+into TTC with 0.5 equivalents of base (Figure
2.9). The TEA( Triethylamine) was added to aid the deprotonation of TTC because our primary
study in DMSO suggested very weak binding. We titrated until we could see precipitation in the
NMR tube. Our runs with Yb3+titration persisted till 4 equivalents. Upon titration of 0.5 eq. of
TEA we immediately observe the disappearance of the OH-6 signal at 5.05 ppm due to increase
in OH exchange with water. But the indication of first binding of Yb3+starts showing up after we
start 0.2 equivalents of Yb3+titration. The very first titration gave rise to isotopically shifted signals
to the up field region as far as -20.5 ppm. We could observe at least 13 isotopically shifted signals
which could potentially be assigned with 2D EXSY experiments. The gradual disappearance of
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OH-12 peak over the course of the titration indicated the first sign of binding. The gradual
weakening of intensity of NH2 signals ( ~9.5 ppm , 9.1 ppm) and the enhancements of OH-10
signals made us to think whether the there is a second Yb3+ binding . OH-12a signal enhancement
with gradual shift downfield confirmed that it is affected by Yb3+ binding. Whether or not it is
due to direct Yb3+ binding at C11-C12 position or conformational change associated with the metal
binding cannot be concluded at this state. We also observed the rapid decrease of NH2 signals after
1 equivalents of Yb3+ has already been titrated . The obvious choice was to monitor the 7.4 ppm
peak of OH-3 position which is supposed to disappear upon binding but being buried in the 1H
signals from ring D it turned out to be a challenge, but we could definitely see the intensity going
down and signal being broadened. So, we took a different approach to investigate; we looked at
the H-4 signals at 4.6 ppm. Upon titrating more than 1 equivalents of Yb3+ the 4.6 ppm signal
becomes less intense with the titration of more Yb3+; signaling the protons getting close to the
Metal center. So it confirmed the Yb3+ binding to N2-O and 3-OH position with more than 1
equivalents Yb3+ addition and then possibly to C10-C11 position at higher concentration. One
important question however remained; the appearance of new signals in the diamagnetic region at
5.40ppm, shifting 7.8 ppm to 8.00 ppm at 0.5 equivalents of Yb3+ titration. Then upon titration of
>0.5 equivalents of Yb3+ we see the formation of 6.2 ppm, 6.4 ppm signals. Altogether we see at
least 2 different new species in the diamagnetic region posing the question whether they are
exchanging with the paramagnetic signals. So we went on to do the 2D EXSY studies to see
whether they are exchanging among themselves or not. As 2D EXSY pulse sequence employs the
correlated isotopically shifted signals to their diamagnetic counter parts by taking advantage of the
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4 Eq Yb(Ill)

3 Eq Yb(Ill)
2 Eq Yb(Ill)
1 Eq Yb(Ill)
0.5 Eq Yb(Ill)
0.2 Eq Yb(Ill)
6.42mM TTC

Figure 2.10: 1H NMR Base titration (0.5 Eq.) of Yb3+-tetracycline complex (Top) and Full
assignment of tetracycline 1H NMR signals (Bottom in collaboration with College of Chemistry
and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, 201620,
China, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China.
paramagnetic signals of the Yb3+ complex of tetracycline HCl (Table 2.1)
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Table. 2.2:1H NMR signal assignment for Tetracycline HCl
Position
C4
C4a
C5
C5a
C7
C8
C9
OH-3

δH( ppm)
4.34
2.84~2.90
2.21,1.79
2.84~2.90
7.12
7.56
6.94
7.47

Position
OH-10
OH-12
OH-12a
CONH2-2
NH+-4
N-CH3-4
CH3-6
6-OH

δH( ppm)
11.81
15.13
10.48
9.56,9.12
16.41
2.84~2.90
1.53
5.05

Xie, J.-H.; Wang, L.; Liu, P.; Su, X.; Ming, L.-J. “NMR Study of the Exchangeable Protons and
Hydrogen Bonding in Tetracycline Hydrochloride” Chin. J. Magn. Reson. 2021, 38, 313–322.

Figure 2.10.1: EXSY 0.1 Eq Yb (III)-0.5 eq. Base
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H-4

H-4
H -5

H-5´
NH2

NH2

Figure 2.10.2: EXSY 0.1 Eq Yb (III)-0.5 eq. Base
As we already have the full assignment of the apO-TTC 1H NMR we went on to assign the
isotopically shifted paramagnetic signals from the titration points to further study the speciation of
the complexes that has been indicated in our primary optical data. Our primary data suggested at
least 2 different species of complexes chemically exchanging with the paramagnetic signals. So
our first obvious choice was to start with excess amount of TTC 2D EXSY. With 0.1 eq. of Yb3+
we have 10 times more TTC in the solution for the first titration point. So we are expecting more
of TTC bound complexes which we see in the EXSY. The 4 NH2 signals in the –20.40,-19.30,13.80,-12.30 could easily be associated with the NH2 signals in the diamagnetic region; suggesting
the presence of two different species; one should be the apO-TTC because clearly all the TTC
unbound is still persisting in the diamagnetic region. The obvious presence of another 5 signals
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from H-4 and H-5, H-5⸍ altogether 3 paramagnetic signal pairs at least at this stage together with
multiple new signals interacting with the diamagnetic region.

H-4
H -5

H-5´

NH2

NH2

Figure 2.11: EXSY 0.5 Eq Yb(III)-0.5 eq. Base
So at this stage we see in the primary equilibrium ; the apO-TTC being the first species
and Yb3+-TTC as second species. Both species are exchanging with each other.
So although the formation of 1:1 Yb3+-complex was almost obvious according to the previous
studies

34, 29

.We

hypothesize that the discrepancy is due to the change in proton activity in the

solution. With our optical job plot with TTC and Yb3+ in DMSO, Mixed solvent system and DMSO
with 2 equivalent of base it was obvious that with more basic environment the TTC was acting
more like a bivalent anion which undergoes deprotonation in different environment and binds to
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metals in progressively higher 1:1, 2:1, 1:2 M to L stoichiometry. As we went on to higher
concentration of Yb3+ in 0.5 equivalent titration in figure 2.11 and 1 equivalent titration in Figure
2.12

we could see the gradual appearance of new signals which are interacting with the

diamagnetic region more and more. Till 1 equivalent of Yb3+ the diamagnetic signals are very well
in the spectrum still well resolved but we see the enhancement of paramagnetic signals in the up
field region; suggesting the equilibrium in shifting more towards paramagnetic species. In this
stage we assume the equilibrium be: with three species: apo TTC with Yb3+-TTC and 2Yb3+-TTC

H-4
H -5

OH-10

OH-12a

OH-12

Figure 2.12: EXSY 1.0 Eq Yb(III)-0.5 eq. Base
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H-5

NH2

NH2

H-4

H-9
H-8
H-7

Figure 2.13: EXSY 4.0 Eq Yb(III)-0.5 eq. Base
After 4 equivalents of Yb3+ we could see the diamagnetic signals almost wiped off while New
signals appearing( H-8, H-9, H-7) suggesting the slow chemical exchange with the diamagnetic
apo species. If we carefully observe the new signls in the figure 2.13 its obvious that the signals
are interacting with the ring strcuture of the diamagnetic sepcies
The strong cross peak at 0.1 ppm (4-H) is assigned to the Yb3+ –TTC complex which is only at
high concentration of TTC in equilibrium with the newly formed -6.8 peak which directly
interacts with H-9 proton of the TTC- D ring indicating the complete formation of the 3rd
species which is 2:1 Yb3+-TTC complex .
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NH2

Ring – New
signals 3,4

H-12a-New
signal 2/OH-10
OH-10-New
signal 1
OH-10-OH-12

NH2

NH2

Figure 2.14: 1H EXSY spectra of 0.2 Eq. Yb3+ without base in 0.6
mM TTC (Bottom), Zoomed into diamagnetic region( Top)
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Table 2.3: T1 relaxation data for Yb3+-TTC complex
Position

δH( ppm)

TTC( ms)

0.1Eq. Yb3+

0.8Eq. Yb3+

1.6 Eq. Yb3+

OH-12

15.07

1376

608.1

156.03

105

OH-10

11.67

1968

625.2

148.5

102.9

OH-12a

10.24

1342

579.3

439.9

349.2

NH2

9.50

1130

820.8

192.4

93.32

NH2

9.07

1134

474.3

165.5

80.18

H-8-Ring

7.55

1914

265.9

348.5

658.1

OH-3

7.40

1402

1672

439

281.8

H-7-Ring

7.09

947.5

712.7

251.3

592.5

H-9-Ring

6.91

2742

902.9

418.2

685.4

We observed that with only 0.2 equivalents of Yb3+ we have the presence of at least 4
different tautomers of TTC in the solution which is evident from the close up of the 1H EXSY at
Figure 2.14 which also suggests all these tautomers are also slowly exchanging among themselves.
That explains why even at 4 equivalents of.Yb3+we could still see exchange in the diamagnetic
region. Some of these tautomers probably do not form complexes and remain in the solution slowly
chemically exchanging among themselves which needs to be investigated further. There could be
as high as 6 number of TTC tautomers in aqueous solution from which we could see at least 4 in
this solution- 35-37. At this high concentration of Yb3+ what we can conclude at best is that in the
presence of Yb3+the C2-C3 and C10-C12 signal’s drastic enhancement of relaxation suggests
significant interaction with paramagnetic metal ion in these positions.
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Spin-lattice Relaxation Time of Yb3+-tetracylcine Complex:
The spin lattice relaxation time or T1 data gives us an idea about how far the protons are
from the metallic center. Even though we didn’t use the T1 data to calculate the distances, the data
however gives us a rough idea about the interaction. Table 2.3 lists all the T1 data from three
different titration points and the data already suggests the binding order which is agreeing with our
optical and 1H NMR data. . Relative distances to the metal for the above protons can be estimated
with one of the fixed ; relatively undisturbed Yb3+−H distance set as the reference21, 29 and
calculated as [(T1/T1(1-CH))1/6 × Reference distance] Å according to the Solomon equation 38. As we
can see from the table 2.3 with 0.8 equivalents of the Yb3+ the OH-12 relaxation time is almost 90
millisecond(ms) shorter which correlates that the Yb3+ binds to C12 not C10. Then again the amide
relaxation times drop significantly right after we titrate 1.6 equivalents of Yb3+ indicating C2 is the
next most affected site; also the massive drop of relaxation time to ~93 ms and ~80 ms indicates
the Yb3+ is closer to binding coordinating oxygen here than the OH-12 coordination site. Yb3+
binding also affects the relaxation time of OH-10 proton. It also suggests the effect of binding are
almost similar for both OH-10 and OH-12 position. So, we can conclude the primary binding
position is C2-C3 and with appropriate condition Yb3+ keeps binding to 2:1 stoichiometry. Then
again the amide relaxation times drop significantly right after we titrate 1.6 equivalents of Yb3+
indicating C2 is the next most affected site; also the massive drop of relaxation time to ~93 ms and
~80 ms indicates the Yb3+ is closer to binding coordinating oxygen here than the OH-12
coordination site. Yb3+ binding also affects the relaxation time of OH-10 proton. It also suggests
the effect of binding are almost similar for both OH-10 and OH-12 position. So, we can conclude
the primary binding position is C2-C3 and with appropriate condition Yb3+ keeps binding to 2:1
stoichiometry. The proposed structure then should be figure 2.15 at high concentration: position
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The proposed structure then should be figure 2.15 at high concentration: position is C2-C3 and
with appropriate condition Yb3+ keeps binding to 2:1 stoichiometry. Our proposed structure then
should be figure 2.15 at high concentration:
Concluding Remarks:
The antibiotic Tetracycline contains a pair of β-ketophenolate groups and a carbonylamido
group which are good candidates for the Yb3+ binding. In this chapter we present c binding study
of Yb3+ with TTC. The optical and NMR study suggested the binding of Yb3+ at the condition we
presented where its slightly basic is primarily through C2-C3 position and then switches to
probably concomitantly or slightly subsequently to the C12 site and C10( Figure 2.15) at high
concentration. Our study essentially had more than 25 mM of Yb3+ in just 600 µl solution.
Depending on the protic environment several different species of 1:1,1:2 metal to drug ratio
present in the solution. A similar study in aqueous solution could be conducted keeping in mind
the various tautomers that could be in the solution. We will have to keep in mind about the
degradation of TTC in aqueous environment in all different ways, possible microbial degradation,

Figure 2.15. Structure of Yb3+-tetracycline complex
complexed with 2 Yb3+.
degradation by chemicals present in the environment which also poses another question about their
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( degraded tetracycline) interaction with environment and related toxicity or outcome
42, 43, 44-49, 45, 50, 50
.

39, 40,

41,

Moreover, with the binding properties similar to other tetracycline. This study

could serve as a model system to study their interaction with metals. We have again shown that
Yb3+ could serve as an essential tool for the structure elucidation of Metal-small molecule
complexes. We could try the other Ln3+ like Pr3+ which interestingly shifts signals to the opposite
of Yb3+ , Dy3+ where the shift is way more wide with more 100 kHz spectral window or Eu 3+ with
the lowest paramagnetic excited state 29. The methodology present here could be employed with
other small molecule which have potential interaction with metals as well. With ubiquitous
presence of metals in the environment and biological system the techniques employed here has
innumerable application and utility.
Materials and Methods:
Materials and pH:
All the materails were purchased from Sigma Aldrich , Alfa Aesar, Cambridge isotope
laboratories. The d6- DMSO , D2O were kept dessicated all the time to prevent atmospheric
moisture from getting into the solution. The HEPES buffers were pH balanced using Fisherbrand™
accumet™ AB15+ Basic and BioBasic™ pH/mV/°C Meters. The meters were always calibrated
using 3 point calibration protocol.
UV vis-spectroscopy :
The optical study awere conducted using Cary 50 UV-Vis spectrophotometer keeping
the temparature with 25 ° C.
NMR Studies: All the NMR studies were performed on the Agilent Inova and direct Drive
spectrophotometrs at a reference proton resonance of 600 MHz. All the samples were prepared at
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~5-20 mM in either D2O or d6-DMSO. YbCl3 6.H2O was used to prepare Yb3+ stock. 1D 1H NMR
was obtained by the use of presaturation in case we observed moisture retension in the sample but
we kept the samples relatively dry using silica dessicator; so it was rare. NOESY and EXSY were
the primary 2D NMR tecniques employed. NOESY was modified by reducing the mixing time to
10-40 ms to reduce NOE builduallowing only fast exchanging (1-20 ms) paramagneticdiamagnetic protons to accrue signals. Spcetra were acquired using 30 kHz spectral window, 64
scans, 512 increments and 2K* 1K points in bot dimentions for processing.
For the paramagnetic 1H NMR recylce time was kept shorter within 250 ms and spectral
window as kept at 83 kHz.
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Chapter Three: Catalytic Nuclearity and O2/H2O2 Specificity of Cu (II) Complexes with
Tetracycline and Oxytetracycline
Background:
For most living organisms the whole chain of activity of the dioxygen is paramount which
spans from transportation to activation and metabolism. These incredibly important functions are
carried out by numerous metalloproteins with either copper or iron5. Iron containing heme proteins
like hemoglobin and myoglobin, cytochrome c oxidase and peroxidase are some of the critical
examples. Among these examples hemoglobin and myoglobin are responsible for dioxygen
transport, cytochrome c oxidase for activation and reduction of dioxygen and peroxidase for
elimination of radical intermediates. Then there are other kinds of metalloproteins which catalyzes
many activities such as the proteins with iron and Cu(II) containing dinuclear metal centers.
Hemerythrin (Fe) and hemocyanin (Cu) are two prime examples. The dinuclear metal centers in
these proteins are closely matched to active sites of some proteins whose prime function are quite
often catalysis rather than dioxygen transport. Among all these one of the most discussed one such
as Cu(II) proteins which have three distinct type based on the spectroscopic properties6 .
Among the three class of copper proteins the first class of copper proteins which are quite
often referred as “blue copper protein” or Type-1 are found in the electron-transport proteins such
as the azurin and plastocyanin.. The “BLUE” comes from the Cys S- Cu(II) charge transfer
transition. Crystal structure reveals the coordination geometry of trigonal planar around the metal
center7 .
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The type-2 copper centers are found at oxidases like galactose oxidase an dopamine-βmonooxygenase. These also prevalent in Cu,Zn-superoxide dismutase. The coordination geometry
is square planar.
The type -3 copper protein contains two copper atoms. These specialized copper centers
can serve multiple purposes as oxygenase , oxidase enzymes or dioxygen transport proteins8. A
perfect example is hemocyanin(HC). Our focus however is on catechol oxidase(CO) which is also
referred to as o-diphenol oxidase. CO exclusively catalyzes the oxidation of catechols ( Ortho (o)diphenols) to corresponding quinones. Another type-3 copper protein Tyrosinase(TYR) on the
other hand catalyzes both the oxygenation( addition of OH) and oxidation on the phenol ring of
the tyrosine . COs are abundant in plant tissues, insects and crustaceans8, 9. The CO in some plants
however surprisingly show monooxygenase activity just like TYR 10. COs in some older literatures
have been referred as TYRs even though COs rarely accept tyrosine as a substrate. COs are also
referred as polyphenol oxidase(PPO), diphenol oxidase(DPO) and quite simply phenol oxidase.
We however are using the term CO only for Catechol oxidase in this study.
The dimetal site of the COs and TYRs exist in several states; the met state, the oxy state
and the deoxy or reduced state .The met state has a Cu(II)-Cu(II) center which a
antiferromagnetically coupled. The blue colored oxy state is available when the dioxygen binds to
the metal center resulting in intense absorption maxima at 343 nm. The deoxy or reduced state has
no antiferromagnetic coupling and bridging ligand like OH in case of the met state2.The Cu(II)Cu(II) distance in met CO of sweet potatoes Ipomoea batatas is reported as 2.9 Å containing 3
histidine 11 coordinated to each copper atom and a bridging oxo/hydroxo ligand For the oxy state
however the distance is 3.8 Å with five N/O atom as coordination atoms12. The coordination sphere
around the metal is trigonal pyramidal according to the same study. The deoxy state has the Cu(I)-
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Cu(I) distance of 4.2 Å and the metal centers are coordinated with 3 N atoms from Histidine and
one water molecule for one Cu(I) and the another Cu(I) is coordinated( coordination number 3)
with three histidines(N) . The coordination sphere is different from the oxy state and is either
distorted trigonal pyramidal for Cu(I) center with 4 coordination and square planar for the other
site; the coordination site for OH- remains vacant. In case of an inhibitor complex however with
phenylthiourea(PTU) the distance however increases to 4.4 Å which is due to S atom of the
inhibitor replacing the bridging ligand OH- in the met state. Even though the coordination site
remains the same there are conformational changes in this case.
The met and reduced state have slightly different position for the coordinating residues.
This indicates the rigidity of the binding pocket. The changes of cordination is related to the copper
atom movement and the inhibitor complex working like a gate which rotates upon binding. The
access to the metal center for the substrate is controlled by this so called gate residue according to
a study12. In the oxy form structure, the peroxide ion binds in a bridging side-on μ-η2:η2 .binding
mode3
Catalytic cooperativity is a natural phenomenon for which we quite often refer to
hemoglobin. Hemoglobin as a multi-subunit and multi-domain protein exhibit cooperativity
while monomeric myoglobin does not

13

. Like that as small molecule like Tetracyclines with

multiple binding sites for metals may exhibit protein-like cooperativity as well as enzymatic
catalytic cooperativity. Tetracyclines (TTC) with widely reported metal binding capacity
exhibit significant diversity in structure and properties which have been discussed in the
introduction section. Dioxygen activation together with oxidation processes catalyzed by redoxactive transition metals complexes with different biomolecules have important functions in the
respiratory chains , pigmentation of skin and fruits, vegetables 8. These functions cover wide
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range of subject matters from medicinal chemistry to environmental issues like degradation of
organic hazards 14 to industrial processes 15.Many di-Cu complexes that we have mentioned .
Like that as small molecule like Tetracyclines with multiple binding sites for metals may exhibit
protein-like cooperativity as well as enzymatic catalytic cooperativity. Tetracyclines (TTC)
with widely reported metal binding capacity exhibit significant diversity in structure and
properties which have been discussed in the introduction section. Dioxygen activation together
with oxidation processes catalyzed by redox-active transition metals complexes with different
biomolecules have important functions in the respiratory chains , pigmentation of skin and
fruits, vegetables 8. These functions cover wide range of subject matters from medicinal
chemistry to environmental issues like degradation of organic hazards 14 to industrial processes
15

.Many di-Cu complexes that we have mentioned in this dissertation which are reported often

Figure 3.1.1. PDB ID: 1WX2, Type 3 enzyme Tyrosinase from Streptomyces
castaneoglobisporus (left) with emphasis on the copper active site; oxy-state3.
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A

B

Figure 3.1.2. PDB ID: 1BT2, 1BT1 Type 3 enzyme Catechol oxidase (left) from sweet
potatoes Ipomoea batatas (ibCO)with emphasis on the copper active site ; reduced
state(A), Cu(II)-Cu(II) met state(B).2

predominantly follow dinuclear pathways like(Figure 3.1.1) type-3 enzymes( catechol oxidase
and tyrosinases) to either hydroxylate or oxidize catechol, phenol and related derivatives by
binding and activating O2 and/or H2O2,2, 8, 16. There has been multiple attempts to investigate
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mechanistic pathways of oxidation reactions by di-Cu-peroxo/oxo complexes including
building mononuclear metal centers by utilizing ligands with multiple-metal binding sites with
hydroxo,phenoxo,alkoxo,peroxo or alkoxo group as bridging ligands16-18.
The aim of this investigation is to reveal mechanism of the metal( Cu) complexes of TTCs in
the oxidation activities of catechol type substrates such as DTBC, Catechol itself .
Results and Discussion:
Cu(II) Binding:
Our study confirms that upon binding of Cu(II) to TTC and O-TTC clear isosbestic points(
Figure;3.2,3.4) are detected which indicates TTC , O-TTC binding to at-least a single site under
fat equilibrium consistent with the works by several other groups19, 20. In case of Cu2+ the shift of
360 nm peak to 390-400 nm and 275 nm to 285 nm clearly matches literature 20. The absorbance
changes due to titrating increasing amount of copper in both TTC and O-TTC indicates
complexation with metals. The literature assigns the peak at 250-300 nm to A chromophore while
the BCD ring contribute to both 250-300nm and 340-380 nm absorption band. The binding in case
of O-TTC follows a different pattern than TTC. The 250-300 nm peak which is attributed to A
ring (C2-C3 carbonylamide) in case of O-TTC shows no peak shift at all while the 340-380 nm
peak shifts two times; once to 380 nm upon addition of 1 equivalent of Cu(II). The binding in case
of O-TTC follows a different pattern than TTC. The 250-300 nm peak which is attributed to A
ring (C2-C3 carbonylamide) in case of O-TTC shows no peak shift at all while the 340-380 nm
peak shifts two times; once to 380 nm upon addition of 1 equivalent of Cu(II) then to 430 nm upon
addition of higher concentration of Cu(II) indicating the C2-C3 position remain unperturbed while
the BCD ring goes through different transformation than TTC. The C2-C3 position remain
unperturbed while the BCD ring goes through different transformation than TTC only to 430 nm
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upon addition of higher concentration of Cu(II) indicating the C2-C3 position remain unperturbed
while the BCD ring goes through different transformation than TTC only.

Figure 3.2: Cu (II) titration into 20 µM Tetracycline HCl in HEPES:MeOH(100mM)

Figure 3.3: Absorbance as a function of Cu(II): tetracycline(TTC) molar ratio at 396 nm
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Figure 3.4: Plot of W\wavelength vs absorbance for the gradual titration of Cu(II) into
oxytetracycline (O-TTC) at a total of 5 equivalents . (O-TTC concentration is 20 µM at pH 7.35
in 50:50 MeOH: HEPES(50mM).
Catalytic Activities: The Cu(II)-TTC complex exhibits notable activity towards the
oxidation of catechol in 1:1 MeOH;HEPES (100 mM) at pH 7.35 and 25 ° Celsius , clearly
revealing enzymatic saturation kinetic profile which is fitted to Equation (2) to find the kinetic
constants such as K

M

and k

cat

( Figure (3.6 ) , table (3.1 )). The complex also shows notable

catalytic proficiency ( CP) following first-order rate constants compared to auto oxidation of
Catechol( 9.90× 102 ). The O-TTC complex with Cu(II) also show similar characteristics except
the catalytic proficiency drops ~ 50% . For both the O-TTC and TTC the k

cat

values remains

roughly within ±10% of each other while the K M for Cu(II)-TTC is roughly 2.5 times higher than
that of the Cu(II)-O-TTC indicating significantly higher affinity for substrate of Cu(II)-O-TTC
(Table 3.1).
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Figure 3.5: Plot of Cu (II) equivalents vs absorbance for the gradual titration of Cu (II)
into Oxytetracycline (O-TTC) at a total of 5 equivalents. (O-TTC concentration is 20 µM
at pH 7.35 in 50:50 MeOH: HEPES(50mM)

Figure 3.6: Plot of rate ( mM/S)of quinone formation versus substrate concentration
[catechol] mM at pH 7.35 of catechol oxidation by Cu(II)-tetracycline (Cu-TTC) in 1:1
MeOH;HEPES(100mM)
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Table 3.1: Kinetic parameters for catechol oxidation by Cu(II)-TTC and Cu(II)-O-TTC
complexes
Complex / substrate

k cat (s¯¹)

K M (mM)

(k cat/K M)(M-1S-1)

CP(kcat/k0)

Cu(II)-TTC/ Catechol

88.0 × 10-4

4.60(±0.70)

1.90

9.90× 102

Cu(II)-TTC/ Catechol/H2O2

55.0 × 10-4

82.10(±9.80)

0.70

6.20× 102

Cu(II)-O-TTC/Catechol

101 × 10-4

1.80(±0.40)

5.65

7.37× 102

Cu(II)-O-TTC/Catechol/H2O2

74.2 × 10-4

14.56(±2.80)

0.51

4.70× 102

In both the cases (TTC and O-TTC) the presence of H2O2 significantly reduces the affinity for the
substrate while also dropping the catalytic efficiency and catalytic proficiency. The Cu(II)
complexes herein shows significant catalytic activity , possibly dinuclear catalysis which will be
discussed later.
Substrate Specificity:
The specificity of Cu(II)-TTC and Cu(II)-O-TTC was further explored with various
catechol containing substrates suc as DTBC, dopamine, epinephrine, norepinephrine( Table 3.2).
All these substrates are efficiently catalyzed by Cu(II)-TTC with CP ranging from (0.15- 61.2)×
102. The large catalytic proficiencies for dopamine, Epinephrine and Norepinephrine compared to
catechol and DTBC pose question about the stability of these neurotransmitters to counter the nonregulated transformation from oxidation at physiological pH in the presence of Cu (II)-TTC or
Cu(II)-O-TTC . The metal catalyzed oxidation however suggests they may be fall victim to
unregulated redox-active metal center mediated oxidative stress. The aerobic oxidation of catechol
and its derivatives by Cu (II)-TTC and Cu (II)-O-TTC complexes is presumably following catechol
oxidase like dinuclear pathway which we will discuss in a later section.
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Table 3.2. Oxidation of catechol containing substrates by Cu(II)-TTC and Cu(II)-O-TTC

Complex / substrate

k cat (s¯¹)

K M (mM)

(k cat/K M)(M-1S-1)

CP(kcat/k0)

Cu(II)-TTC/ Catechol

88.0 × 10-4

4.60(±0.70)

1.90

9.90× 102

Cu(II)-TTC/ Catechol/H2O2

55.0 × 10-4

82.10(±9.80)

0.70

6.20× 102

Cu(II)-O-TTC/Catechol

101 × 10-4

1.80(±0.40)

5.65

737× 102

Cu(II)-O-TTC/Catechol/ H2O2

74.2 × 10-4

14.56(±2.80)

0.51

4.70× 102

Cu(II)-TTC/DTBC

27.2 × 10-4

3.91(±0.73)

0.71

15.6× 102

Cu(II)-TTC/DTBC/ H2O2

99.6 × 10-4

13.5(±3.70)

0.74

3.40× 102

Cu(II)-O-TTC/DTBC

1.60× 10-4

8.70(±01.50)

0.16

0.15× 102

Cu(II)-O-TTC/DTBC/ H2O2

7.60 × 10-4

12.70(±1.48)

0.06

0.71× 102

Cu(II)-TTC/ Dopamine

29 × 10-4

6.57(±1.19)

0.44

44.3× 102

Cu(II)-TTC/ Epinephrine

2.83 × 10-4

2.02(±0.42)

0.14

41× 102

Cu(II)-TTC/ Norepinephrine

18.5 × 10-4

2.47(±0.57)

0.75

612× 102

Figure 3.7. Plot of rate ( mM/S) versus substrate concentration [DTBC] mM at pH 7.35
of DTBC oxidation by Cu(II)-Tetracycline (Cu-TTC)
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Catalytic Specificity and Mechanism:
In some biochemical systems such as catechol oxidase, peroxidase and tyrosinase H2O2

Figure 3.8. Plot of rate ( mM/S) versus substrate concentration [DTBC] mM of DTBC
oxidation by Cu(II)-tetracycline (Cu-TTC) at pH 7.35 in the presence of H2O2 . The H2O2
concentrations are (●) 10 mM, (o) 16 mM, (▼) 32 mM, (∆) 64 mM, (■) 128 mM
acts as an oxidative agent which quite often requires activation 2,21,22. k cat value for the oxidation
of DTBC by Cu(II)-TTC at different concentration of H2O2 have been determined ( Figure 3.9).
The plot ( Fig 3.9)of k cat as a function of H2O2 concentrations reveals direct binding of H2O2 to
Cu(II) by showing a saturation kinetic pattern which indicates the formation of possible. The plot
( Fig 3.9)of k cat as a function of H2O2 concentrations reveals direct binding of H2O2 to Cu(II)
by showing a saturation kinetic pattern which indicates the formation of possible. The required
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Figure 3.9. Plot of k cat (s-1) versus substrate concentration [H2O2] mM at pH 7.35 of
DTBC oxidation by (1:1)Cu(II)-tetracycline (Cu-TTC) in the presence of H2O2 in 100
mM (1:1) HEPES/Methanol and fitted to pre-equilibrium kinetics Equations.

Figure 3.10 Plot of rate ( mM/S) versus substrate concentration [H2O2] mM at pH
7.35 of DTBC oxidation by Cu(II)-tetracycline (Cu-TTC) .
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Figure 3.11. Hanes Plot of rate [H2O2]/V0 versus substrate concentration [H2O2] mM at pH
7.35 for the oxidation of DTBC by Cu(II)-tetracycline (Cu-TTC) in the presence of certain
fixed concentration of H2O2 . DTBC (●) 1 mM, (o) 2 mM, ▼ 4.00 mM,(∆) 8mM, (■) 16 mM,
□32 mM

Figure 3.12. Hanes Plot of rate [DTBC]/V0 versus substrate concentration [DTBC]mM at pH
7.35 for the oxidation of DTBC by (Cu-TTC) in the presence of H2O2 . The H2O2 concentrations
are (●) 0 mM,(o)10 mM,(▼)16 mM, (∆) 32 mM, (■) 64 mM, (□) 128 mM
activation 2, 21, 22. k cat values for the oxidation of DTBC by Cu(II)-TTC at different concentration
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Figure 3.13. (o) Slope and (●) Y-intercept as a function of [H2O2]-1 from Hanes Plot of rate
[H2O2]/V0 versus substrate concentration [H2O2]mM at pH 7.35 for the oxidation of DTBC
by Cu(II)-Tetracycline (Cu-TTC) in the presence of H2O2 .

of H2O2 have been determined ( Fig 3.9) . The plot ( Fig 3.9)of k cat as a function of H2O2
concentrations reveals direct binding of H2O2 to Cu(II) by showing a saturation kinetic pattern
which indicates the formation of possible ternary peroxo–([di-CuII]–DTBC) intermediate in the
presence of DTBC. By fitting this plot to equation 2(materials and methods 4.2) we determined
the overall k cat (9.20 s-1) , K M ( 140 mM) , under saturating conditions of both DTBC substrate and
H2O2 and catalytic proficiency(CP) of 1.70× 102 for the oxidation of DTBC in the presence of
saturating amount of peroxide. Our study with O-TTC also results in the same trend with slightly
lower K M, higher k cat and lower CP( table 3.2).
his trend of peroxide saturation kinetics follows a pathway where the oxidation of the
substrate (DTBC/catechol) by the possible di-Cu(II) center( confirmed later) is the rate limiting
step4 .Our proposed pathway is consistent with saturation kinetics with a reversible peroxide
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binding which is followed by DTBC oxidation by the bound peroxide( path c -Fig 3.12.) The
mechanism suggests a bi-substrate pathway with both the catechol substrate and H2O2 binding to

Figure 3.14 .Different stablished mechanism of DTBC oxidation by Cu(II) complexes4
the Cu(II) center
and forms a ternary complex peroxo–([di-CuII]–DTBC/ catechol) . The significant increase in K
M,

k cat and the net loss of catalytic specificity (k cat/ K M ) value in the presence of peroxide for Cu(II)-

TTC indicates specificity towards DTBC oxidation by air instead of peroxide; whereas the
significant loss of the catalytic specificity in the presence of peroxide in case of O-TTC indicates
specificity towards DTBC oxidation in the presence of H2O2 ( table 3.3).
To investigate the trends and affinities for the binding of catechol substrate and H2O2 to
metal center , the rate constants of DTBC under various concentration of H2O2 were calculated(
Fig 2.6) and fitted to the equation 3 ( Hanes plot described in the method section)23 . The
secondary plots of the slopes and y-intercepts as function of 1/[ H2O2 ] (Fig 3.13 ) yields KappDTBC
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of 3.55 mM , KappH2O2 of 18.5 mM and KintDTBC of 2.56 mM. The intrinsic dissociation constant K
int

DTBC

is almost half to the K M without peroxide( Table 3.3) indicating bi-substrate mechanism.

The ratio

𝐴𝑝𝑝
𝑖𝑛𝑡
𝐾𝐷𝑇𝐵𝐶
/𝐾𝐷𝑇𝐵𝐶 (1.40) reflects the binding of peroxide to the Cu (II) center slightly

weakens DTBC binding affinity and thus suggests exclusivity.
Following the same method for O-TTC with the Hanes analysis of the rate vs [H2O2] plots
at various DTBC concentrations (Fig 3.11) where the DTBC and H2O2 were switched in the
equation 3 yields KappDTBC of 8.5 mM, Kapp H2O2 of 11.05 mM and K int H2O2 of 1.40 mM. The ratio
Kapp H2O2 /Kint H2O2 of 7.90 reflects the binding of DTBC also decreases the peroxide affinity to the
Cu (II) center; indicating exclusivity. Both the findings are consistent with random bi-substrate
mechanism, where the active ternary peroxo–([di-CuII]–DTBC/ catechol) complex is formed by
independent binding of catechol/DTBC and H2O2 to the Cu (II) center which is also marginally
exclusive towards the two substrate. (Table 3.3).
We followed the same method for O-TTC with the Hanes analysis of the rate vs [H2O2]
plots at various DTBC concentrations (Fig 3.11) where the DTBC and H2O2 were switched in the
equation 3 yields KappDTBC of 8.5 mM, Kapp H2O2 of 11.05 mM and K int H2O2 of 1.40 mM.
The ratio Kapp

H2O2

/Kint H2O2 of 7.90 reflects the binding of DTBC also decreases the

peroxide affinity to the Cu (II) center; indicating exclusivity. Both the findings are consistent with
random bi-substrate mechanism, where the active ternary peroxo–([di-CuII]–DTBC/ catechol)
complex is formed by independent binding of catechol/DTBC and H2O2 to the Cu (II) center which
is also marginally exclusive towards the two substrate. (Table 3.3). Table 3.3 summarizes the
calculated kinetic parameters for both the TTC and O-TTC.
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3.55 mM( ±0.26)
2.56 mM( ±0.14)
18.5 mM( ±2.53)
10.90mM( ±0.65)
1.40
1.70

𝐴𝑝𝑝
𝐾𝐷𝑇𝐵𝐶

8.5 mM(( ±0.45)

𝑖𝑛𝑡
𝐾𝐷𝑇𝐵𝐶

1.30 mM(( ±0.12)

𝐴𝑝𝑝
𝐾𝐻2𝑂2

11.05mM(( ±0.42)

𝑖𝑛𝑡
𝐾𝐻2𝑂2

1.40 mM(( ±0.18)

𝐴𝑝𝑝
𝑖𝑛𝑡
𝐾𝐷𝑇𝐵𝐶
/𝐾𝐷𝑇𝐵𝐶

6.54

𝐴𝑝𝑝
𝑖𝑛𝑡
𝐾𝐻2𝑂2
/𝐾𝐻2𝑂2

7.90

Cu(II)-O-TTC

𝐴𝑝𝑝
𝐾𝐷𝑇𝐵𝐶
𝑖𝑛𝑡
𝐾𝐷𝑇𝐵𝐶
𝐴𝑝𝑝
𝐾𝐻2𝑂2
𝑖𝑛𝑡
𝐾𝐻2𝑂2
𝐴𝑝𝑝
𝑖𝑛𝑡
𝐾𝐷𝑇𝐵𝐶
/𝐾𝐷𝑇𝐵𝐶
𝐴𝑝𝑝
𝑖𝑛𝑡
𝐾𝐻2𝑂2
/𝐾𝐻2𝑂2

Cu(II)-TTC

Table 3.3: Hanes plot constants for DTBC and H2O2 of Cu(II)-TTC and Cu(II)-O-TTC complex

Mechanism and Nuclearity:
Since the substrate bound ternary peroxo–([di-CuII]–DTBC/ catechol) complex in both the
cases of TTC and O-TTC is the active intermediate form, we can employ the “Mechanistic Job
Plot”3, 24-26 to find out the stoichiometry during catalysis.6,46,47. The oxidation of catechol by both
Cu(II)-TTC and Cu(II)-O-TTC exhibit a maximum at x Cu-L ~0.6-0.7( Fig 3.14, 3.15) which reveals
a Cu-L/catechol/DTBC ratios of roughly 0.33:0.67. As because the 1:1 Cu(II)-L complexes were
investigated in this study the metal-complex to substrate stoichiometry in the active ternary
complex is 2:1 which indicates a dinuclear catalytic pathway by assembling two Cu(II) centers
to form the intermediate [Cu(II)-TTC]2-catechol/DTBC ternary complex. H2O2 presence in both
the cases of tetracycline and oxytetracycline significantly enhances the rates but the overall
mechanism and nuclearity however stays similar.
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Relative Activity of Other Systems vs Cu(II)-TTC and Cu(II)-O-TTC:
The oxidative activity of Cu(II)-TTC and Cu(II)-O-TTC complexes are comparable to the
k cat and K M values of other Cu(II) complexes which range from (0.33-2.5) × 10-4 -1.5 s-1 and K M
of 0.071-2.0 mM 4, 23. Although the comprehensive comparison between the Cu(II) multinuclear
complexes are not exactly representative of the actual situation because all these studies were
conducted in different conditions like temperature, pH and solvent systems but the comparison
does help to make a base activity level. For the catechol oxidase the best values so far has been K
M of

2.5 mM and k cat of 2.293 × 103 s-1 which is massive compared to Cu(II) –TTC or Cu(II)-0-

TTC complexes. Our complexes however matches closely with hemocyanin with di-Cu
coordination sites which has a relatively close K

M of

2.6-250 mM and k

cat

of 0.0035-0.183 ×

103 s-1 1, 27, 28.The kinetic constants for DTBC oxidation by different multinuclear Cu(II) complexes
were reported as K M of 0.35-5.00 mM and k cat of 0.038-9.0s-1 which in our case matched with
the K M but significantly differs from the k cat 2, 5, 11, 18, 29-33 .
Cu(II)-TTC complex also oxidizes( Table 2.2) the dopamine with kinetic parameters which
closely resembles which are available at literature for the β-amyloid peptide oxidation by Cu(II)
complexes( K M of 0.27-.90 mM and k cat of 0.748-28.0s-1 )34-38. In our case the pH was however
7.35 instead of 7 and the the K M of 6.67 mM indicates weaker binding of the intermediate complex
which for the studies reported earlier are > 1 mM.
Both Cu(II)-TTC and Cu(II)-O-TTC shows catalytic specificity although to different
extents. Cu(II)-TTC shows very slight catalytic specificity towards H2O2 in DTBC oxidation
((0.71 vs 0.74) M-1S-1 ) while it significantly favors catechol specificity in aerobic condition rather
than peroxidative condition ((1.90 vs 0.70) M-1S-1 ) . This trend of specificity towards aerobic
oxidation persists with Cu(II)-O-TTC as well but to a larger extent which is (5.65 vs 0.51) M-1S-1
74

for catechol . However in case of O-TTC for DTBC oxidation the specificity shifts towards aerobic
significantly which is (0.16 vs 0.06) M-1S-1 . This trend is not quite common if we consider the
reported scenarios where it more tilts towards H2O2 37, 39-42.
Conclusion:
I hereby report the activities, mechanism and catalytic specificity of the Cu(II) complexes
with TTC and O-TTC towards the oxidation of catechol and related derivatives. The investigation
reveals the involvement of dinulear Cu (II) centers in the process of catalysis. Dinuclear Cu (II)
complexes are quite common exhibit oxidation and oxygenation activities by the use of molecular
oxygen or/and H2O2. However complexes with relatively specific substrate recognition; O2/H2O2
specificity are hard to come by. Both the TTC and O-TTC complexes exhibit these properties to
different extents.

Figure 3.15. Mechanistic Job Plot of rate for the oxidation of Catechol by Cu(II)-Tetracycline
(Cu-TTC) at a total concentration ( [complex]+ [Catechol]) of 60 µM at pH 7.35 in 50:50
MeOH: HEPES(50mM)in the presence(o) and absence(●) of 250 mM H2O2. The solid traces
are best fits to Cu(II)-TTC/ Catechol ratios of 2:1 , whereas the dotted trace represents a ratio
of 1:1 in the absence of H2O2 .
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Figure 3.16. Mechanistic Job Plot of rate for the oxidation of DTBC by Cu(II)Oxytetracycline (Cu-O-TTC) at a total concentration ( [complex]+ [DTBC]) of 60 µM
at pH 7.35 in 50:50 MeOH: HEPES(50mM)
Materials and Methods:
Materials: The Cu(II) complxes were prepared by mixing stoichiometric amout of Cu(II)
(99.99%) and TTCs in 1:1 Methanol: 100 mM HEPES buffer at physiological pH of 7.35 for both
optical and kinetic measurements . All the water were from millipore sigma water system and
prepared right before the experiments.

Kinetic Measurement:
The initial oxidation rates of DTBC (3,5-di-tert-butyl catechol) by 10 µM Cu(II)-TTC
complexes in 1:1 MeOH:HEPES( 100mM) at pH 7.35 were measured by monitoring the
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absorption change at 420 nm owing to the formation of quinone product( ɛ =1910 M-1 cm-1).The
rates of catechol oxidation were monitored at 500 nm by attributed to the formation of o-quinoneMBTH product adduct ( ɛ =32500 M-1 cm-1). The p-quinone isomer absorption was ignored due
to insignificant absorption at this range.
Just like enzymatic pre-equilibrium kinetics the substrate binds to Cu(II)-TTC catalytic
center and subsequently forms an intermediate Cu(II)-TTC-S complex which eventually results in
the formation of quinone products as enumerated in equation 1 . The rate law for this reaction is
shown in equation 2 with the apparent dissociation constant 𝑲𝒎= (𝒌-𝟏+𝒌𝒄𝒂𝒕)/𝒌𝟏) which is
analogous to Michaelis constant assuming the concentration of the intermediate is way lower than
the substrate concentration. The initial rates for different concentration of the substrate oxidation
were plotted against the concentration of the substrates and subsequently fitted to equation 2 with
non-linear regression in the SigmaPlot 12.0 to obtain the rate constants which are k cat and K M .

Eq.1
𝑽𝒎𝒂𝒙[𝑺]

V0=

𝑬𝒒.2

𝑲𝑴+[𝑺]

The presence of pre-equilibrium kinetics in the enzymatic catalysis of oxidation of catechol
facilitates the utilization of ‘mechanistic Job plot’13 to find out the stoichiometry of Cu(II)-TTC
bound to S in the reaction mechanism. By monitoring the rate of the reaction that essentially
reflects the intermediate concentration we can practically figure out the stoichiometry of the
intermediate by means of the mechanistic Job plot. Our experimental set-up kept the total
concentration of Cu (II)-TTC and S constant to 60 µM while varying the ratio between Cu (II)TTC and S . The plotting of Rate (mM/S) vs the mole fraction of the complex X Cu-TTC in the job
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plot reflects the stoichiometry of the ternary complex which in our case was XCu-TTC ~0.66
reflecting binuclear catalysis. In the presence of a second substrate such as H2O2 the catalysis is
bi-substrate catalysis which can be probed with the Hanes plots 13 . The dissociation constants for
each substrate in the presence of the other can be calculated according to equation 3

[𝑆]
𝑉0

=

(1+

𝐴𝑝𝑝
𝐾
𝐻 𝑂
2 2
[𝐻 𝑂 ]
2 2

𝑉 𝑚𝑎𝑥

𝐾𝑖𝑛𝑡
)

𝐴𝑝𝑝
𝐻 𝑂 × 𝐾𝐻 𝑂
2 2
2 2

𝐴𝑝𝑝
𝐾𝑆

[𝑆] +

1+

𝑉 𝑚𝑎𝑥

Eq.3

[𝐻2𝑂2]×𝐾𝐴𝑝𝑝
𝑆

(

)

the experimental design is set up to measure initial reaction rate for one substrate in the presence
another substrate with systemic variation. The rate law that has been utilized for this catalysis is
Equation 3, where S is either catechol or DTBC and H2O2 is the other substrate . K

app

S , K app

H2O2 are the apparent dissociation constants for the ternary complex with both H2O2 and catechol
bound to the catalytic center such as (catechol)-[Cu(II)-TTC]-(H2O2 ) ↔[Cu(II)-TTC]-(H2O2) +
(catechol) and (catechol)-[Cu(II)-TTC]+ (H2O2) respectively, and K

int

H2O2 is the intrinsic

dissociation constant in (catechol)-[Cu(II)-TTC]↔[Cu(II)-TTC]+ (catechol). The dissociation
constants were calculated by secondary plots of the slope and y-intercept as a function of H2O2-1.
In case the binding of one substrate somehow effects the other or vice versa there should be a
significant difference between the constants.
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Chapter Four: Inhibition of Copper (II)-tetracycline Mediated Oxidation by Salicylic Acid,
Benzoic acid and Bacitracin
Background:
Tetracyclines in the Environment:
Antibiotics as a lifesaving drug of miracle have been indispensable in medicine for almost
a century since the discovery of penicillin in 1928. The non-medicine role of antibiotics or
Nontherapeutic antibiotic use started growing in reputation almost immediately from 1935 3. )
when

German

pharmaceutical

manufacturer

Bayer®

started

marketing

Prontosil

(sulfochrysoidine) for Gram-positive infection in animals. Later other countries quickly caught up
with this practice and it started to grow into other sections of agriculture including growth
promotion. In 1949 American Cyanamid’s Lederle Laboratories found that feeding low-dosed
antibiotic to domestic animals increases their weight gain apart from protection against bacterial
infection 4, 5, 6. After the Second World War the booming post-war appetite for meat in the US led
the farmers to adopt this practice which rapidly spread across the globe. On top of that antibiotics
were used on farm animals prophylactically to prevent infection from happening Soon after that,
the subtle difference among uses of antibiotics as therapeutic , growth promoter and prophylaxis
was blurred by mid the mid-1950’s.
streptomycin sprays and solutions were used to treat and prevent bacterial plant infections like
modern day COVID-era sanitizers. Meanwhile, the new wonder tetracycline preservatives started
being massively used in the US fish, shellfish, and poultry industry7 . According to the US FDA
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report in 2019; 36% of the entire sales by volume of antimicrobials for animal use was still
tetracycline and after 27% drop from the level in 2010 8. The sheer volume was 4.12 million kg.
The massive volume of TTC used in agriculture for decades after decades rendered probably
millions of kg of TTC are released in the environment un-metabolized every year.
Antibiotics are complex molecules with various functional groups that are getting even
more complicated as new generations of antibiotics are rolling in every year. The use of antibiotics
have been growing at unprecedented rate ever since the inception and subsequent roll out. The
annual global usage of antibiotic reached two hundred thousand tons from one hundred thousand
tons in 2015 9 )According to a study between 2000 and 2015 antibiotics usage in 76 countries shot
up 65% constituting 42 billion Defined daily doses(DDD)9. The major consumers of antibiotics
are middle and low-income countries like India, Pakistan and China which together contains
almost half the population of the globe 10. By 2030 this usage is expected to grow 200% and mostly
in low and middle-income countries. While the trend is reversing in developed countries with
relatively strict control and awareness among the population but there is still massive usage. The
more detailed study regarding the usage of antibiotics in EU and US are available and the data of
massive usage is astounding

11

.

The continuous release of massive amount of antibiotics in the environment and potential
adverse effect is of great concern for us

12, 13, 14, 15,16

. Humans and animals cannot metabolize the

antibiotics completely, so majority of the un-metabolized drugs are released (42-72%) into the
environment as sewerage waste, manure, sewage sludge, organic materials from waste treatment(
biosolids) etc.
fertilizers

17

. All these releases in turn are used in agriculture as irrigation material and

18, 19, 20

. Approximately 75–80, 50–90, and 60% of the doses of tetracyclines,

erythromycin, and lincomycin, respectively, are excreted via urine and feces
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21,22

. Reported

antibiotic concentrations in wastewater vary drastically and range from ng/mL to µg/mL

23,24,25

.

The concentrations of antibiotic residues in the environment (soil layers, sewage sludge, biosolids,
and manure show significant variations and depends on a lot of things including type of drugs,
animal type and duration of exposure etc. Several study suggests Tetracyclines have the highest
concentrations in animal manure (358 mg/kg for O-TTC, 98 mg/kg for TTC) and it has been most
frequently reported 26, 27,28.
There has been cautions among scientists about potential hazard of antibiotics in the soil
and the concentration of antibiotics in the soil has been reported in the range of ng -mg /kg of soil
.predictably the highest concentration are always in the vicinity of heavy manure usage and
livestock raising places

29, 30, 31

. The concentrations of tetracycline, oxytetracycline and

chlortetracycline can be surprisingly high in agricultural real estate and they vary largely. It ranges
from 50 mg/kg ( O-TTC) to 2.83 mg/kg (TTC) of soil according to reported values which as
mentioned vary significantly depending on location 32.
There has been cautions among scientists about potential hazard of antibiotics in the soil
and the concentration of antibiotics in the soil has been reported in the range of ng -mg /kg of soil
.predictably the highest concentration are always in the vicinity of heavy manure usage and
livestock raising places

29, 30, 31

. The concentrations of tetracycline, oxytetracycline and

chlortetracycline can be surprisingly high in agricultural real estate and they vary largely. It ranges
from 50 mg/kg ( O-TTC) to 2.83 mg/kg (TTC) of soil according to reported values which as
mentioned vary significantly depending on location 32.
These scary high concentration of antibiotics in soil causes preferential outgrowth of
resistant bacteria 33, 34, 35 48,49,50, 51 and changes the sensitivity for the entire microbial population of
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Table 4.1. Maximum concentration values (µg kg-1) for tetracycline antibiotics detected in
agricultural soils of different countries. 47. (TTC): tetracycline; (O-TTC): oxytetracycline;(
CTC): chlortetracycline
Country
TTC
O-TTC
CTC
Reference
China

22.0

423.0

120.0

36

China

105.0

2683.0

1079.0

37

China

189.8

613.2

2668.9

31

China

153

571.4

10,967.0

38

China

74.4

79.7

104.6

39

China

60.4

415

222.0

10

China

25.7

31.9

161.5

26

China

976.2

1398.5

1590.2

40

China

197.0

530.0

-

33

Denmark

-

-

15.5

41

Germany

443.0

27.0

93.0

42

Korea

177.6

0.7

0.9

14

Korea

2.9

3.8

0.9

43

Malaysia

-

-

-

44

Spain

64.3

105.4

34.4

45

Spain

-

-

-

17

Spain

600

200

-

17

UK

-

305.0

-

46

,

These scary high concentration of antibiotics in soil causes preferential outgrowth of
resistant bacteria 33, 34, 35 48,49,50, 51 and changes the sensitivity for the entire microbial population of
the vicinity. These scary high concentration of antibiotics in soil causes preferential outgrowth of
resistant bacteria 33, 34, 35 48,49,50, 51 and changes the sensitivity for the entire microbial population of
the vicinity which leads to transferring into humans and colonizing there with the resistant genes.
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Figure 4.1.Fate of tetracycline in the presence of metal ions in the environment2

eventually leads to transferring into humans and colonizing there with the resistant genes. Such
genes have been found in the soil samples 38.
Tetracyclines and Secondary Metabolites:
Once the TTC’s are in the soil environment they can interact with various organic matter
in the soil through all different mechanisms. The first obvious way is cation interaction between
the + charged ammonium functional group of TTC’s and the H+ of various carboxylates such as
Benzoate, salicylate etc. Then comes the hydrogen bonds between polar groups on the TTC’s (OH, =O) and the acid groups on the metabolites. The last one is TTC’s can interact with
multivalent cations like transitional metals(M) to form ternary complexes like SA-M-TTC. For
our study we have selected two common secondary metabolite found in the environment SA and
BA. We also selected Bacitracin based on its heavy use in agriculture and its capability to bind
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transition metal ions and ligands. In the latter study, the interaction between two different metalbinding antibiotics and the role of metal in such interaction are revealed.
Salicylic Acid:
SA or 2-hydroxybenzoic acid is one of the oldest and popular medicines of the world. It is
produced by the bark of the willow tree ( Salix alba) and named after it. Our everyday ASPIRIN
is the acetylated form of salicylic acid which is one of most used medication of the world. There
have been reports of willow barks medicinal property from the time of Hippocrates 52. The source
of SA varies among different common plats like rice, tobacco and surprisingly in certain varieties
of potatoes

53

. It is a very common plant hormone which acts as an antibiotic, oxidative stress

reliever and growth hormone 54. SA has been reported to have antibiotic activity against E.coli 55.
It’s amazing that it has been around for 3000 years as a medicine; naturally produced for millions
of years and its roles are still being investigated. The pharmacological activities of SA as a
Nonsteroidal anti-inflammatory drug( NSAID) are reducing pain, fever and decreasing
inflammation. The anti-inflammatory action of SA is due to its interaction with cyclooxygenase-2
receptors (COX-2). The COX-2

are responsible for causing inflammation by inducing

prostaglandin hormones 56 .SA however does not exhibit any activity with COX-1 in-vitro.
SA interaction with transitional metals has been reported in 1950’s. The reported affinities
with different metals are in the order of Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+. In addition to
its antioxidant activity , SA has exhibited significant antioxidant activity towards redox active
metals 57 . The results presented in this chapter includes the interaction of SA with Cu(II)-TTC via
the detection of the anti-oxidative activity of SA against Cu(II)- mediated oxidation of catechol.
Therein, a competitive inhibition pattern reflect direct binding of SA to the redox-active Cu(II)
center that prevent the catechol substrate from binding to the metal center.
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Bacitracin:
Bacitracin (BC) as tropical antibiotic was first discovered and published in 1945 and
approved by the US FDA for treatment of skin infections. The amazing thing about this discovery
by Johnson, et al was the fact that it was isolated from the blood culture of a seven-year-old
Margaret Tracy in NY and was actually named after misspelling her last name TREACY’s to
tracin. It was originally derived from Bacillus subtilis but now commercially cultured from the
strain of Bacillus licheniformis. 58.

Figure 4.2: Bacitracin A1
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Bacitracin is active against a narrow body of microorganism. Several strains of staphylococcus
and streptococcus , and some Gram + bacteria are susceptible to BC. The popular brand topical
antibiotic Neosporin® and Polysporin® are combination antibiotics of bacitracin. Just like
bacitracin it is very commonly used as growth promoter with animal feed and prevention of Gram
+ infections. It’s poorly absorbed from GI tract , so the dosage forms are topical ointments. The
massive use of BC somehow still haven’t triggered widespread resistance development which is a
matter of interest to many 59 .
The sequence of amino acids for BC was first elucidated in 1940 and 50’s. The analytical
techniques in those days were able to resolve several different congeners from A1-2 , B1-3, D1-3 , and
F 60,61, 62 . With modern separations technique 50 more congeners were able to be resolved 63. The
biologically active form was A1 and B1 while F was the most inactive form. Currently the most
common commercial form bacitracin is the Zinc (II) bound form which is reported to be 10 times
more potent than the apo form. The BC as a metalloantibiotic has affinity towards various
transitional metals and the order is Cu2+>Ni2+>Co2+~Zn2+>Mn2+

64

. Bacitracin works by

complexing with the transitional metal ( e.g.Zn2+) and then binding with with a lipidpyrophosphate and then inhibiting the dephosphorilation of the lipidpyrophosphate to complete its
sugar-carrying capability; eventually preventing cell wall synthesis 65.
The metal binding moieties in BC have been determined to be the thiazoline nitrogen
derived from Cys-2, the imidazole-N of the side chain of His-10 and the γ-carboxylate of Glu-4
66,61

. Co2+ complex of BC was resolved by full assignment of the paramagnetically shifted signals

by means of various 1D and 2D NMR methods and correlate the distances of their corresponding
protons to the metal center by means of paramagnetic relaxation61 .
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Metallo- bacitracin can perform myriad of activities part from preventing cell wall synthesis.
Cu(II)–Bacitracin can perform catechol oxidase like reactions. The turnover number for the
oxidation of catechol to the quinone product found to be 7.0 × 10-3s-1 and 0.38 s-1 respectively
aerobically and in the presence of H2O267 . Our justification for investigating BC as an inhibitor of
catechol oxidation roots to this study. CO is a very important enzyme in nature and soil. The
abundance of catechol and polyphenol producing plants, vegetables and fruits are all around us.
Bacitracin as an antibiotic rooted from the sail living bacteria Bacillus have ample scope to interact
with all the catechol and polyphenol containing secondary metabolites in the solid environment.
Moreover, oxidation of catechol is a very standard model system to measure redox activity and the
acquired kinetic parameters can be compared with many those from many other chemical and
biological system
Benzoic Acid:
BA is own natural choice right next to SA as an inhibitor because Benzoate is the
immediate precursor of salicylic acid biosynthesis in higher plants 68 and can serve as a control for
SA as it does not have the phenol group to form a chelating phenocarboxylate moiety found in SA.
Plants have scores of benzoic acid derivatives as bio-precursors like salicylic acids , phydroxybenzoic acids, 2,3-dihydroxybenzoic acids, gallic caids, p-aminobenzoic acids etc 69. For
hundreds of years it has been used against fungal growth, as a preservative in prickles

70

. These

Bas are essentially the building blocks or very critical structural elements for various primary and
secondary metabolites in plants 69. Like salicylic acid many of the plant hormones are essentially
bio-synthesized from different BA derivatives. Its ubiquitous in plants and thus in the soil
environment.
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Chemically it is the simplest of aromatic carboxylic acids , also referred commonly as
phenolic compounds because of phenol ring. The esters and salts of benzoic acid is called benzoate
and that what we used in this study for better solubility. The pKa of benzoic acid is 4.202 71 in water
and 11.02 in DMSO, thus a very weak acid in DMSO.
The idea behind this study is simple. Three compounds were chosen that have the
possibility of coming into contact in the environment and are able to bind to metals. The goal is to
reveal whether or not (micro)biochemicals with metal-binding capabilities can interact with
metallO-TTCs which in turn may alter the bioactivities of these (micro)biochemicals and TTCs
that may play some previously unknown roles in chemical ecology of the environment.
Results and Discussion:
Inhibition against Cu (II)-TTC
Aerobic Oxidation: The previous study (Chapter 3) confirms that Cu (II)-TTC
complex shows significant catalytic activity towards catechol oxidation. The metal center
predictably plays a critical role in this activity which has also been demonstrated in our study. In
this study we are studying the effects of some secondary metabolites on the redox activity of
Cu(II)-TTC which are readily available in the environment. Our choice of metabolites benzoic
acid, salicylic acid are phenolic compounds which are widely available in the plants and
environment, while bacitracin is a topically used antibiotic that is highly used as a growth promoter
in animals and thus available in the soil through animal waste 72. The mechanism through which
Cu (II)-TTC catalyze the oxidation of catechol have already been discussed in the earlier chapters.
We proposed that it follows a mechanism based on di-Copper center. It’s widely known that to
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oxidize catechol into subsequent quinone we require a two electron transfer process 1, 73-82. We
investigated the oxidation of catechol derivatives which is DTBC under aerobic and H2O2 .

Figure 4.3. Suggested catechol oxidation by catechol oxidase1 adapted with
permission from Springer Nature.
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In the following studies DTBC was used a model substrate together with H2O2 as one
oxidation agent Investigating a model catechol like DTBC may assist us to compare the oxidative
reactions occurring in the environment. The myriad of catechol produced by plants is considerably
diverse. (Figure 3.2)

Figure 4.4.Some polyphenol and catechol-containing secondary metabolites produced by
plants

Catechol are abundant among plants and environment. As they don’t play a direct role in
the metabolic activities of plant life they are termed as secondary metabolites. They have shown
considerable ability to reduce Reactive Oxygen Species (ROS) generation and subsequently
preventing genetic and metabolic damage. There has also been reported antibiotic activities

83, 84

.

The potential antibiotic activity is not limited to plant life only but also into protection from UVB light radiation through skin care products 85, 86.
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Oxidation of DTBC by Cu (II)-TTC under aerobic conditions reflects very identical kinetic
pattern similar to Michaelis–Menten kinetics, which shows a saturation in activity of DTBC
(Figure 4.5)

Figure 4.5: Plot of rate ( mM/S) versus substrate concentration [DTBC] mM at pH
7.35 of DTBC oxidation by Cu(II)-tetracycline (Cu(II)-TTC) in 1:1
MeOH;HEPES(100mM) at 25 °C.

Figure 4.6. Simplified aerobic catechol oxidase like pathway for oxidation of
DTBC by Cu(II)-TTC

We made a deliberate effort to make sure that the conditions remain comparable with the
previous studies and the solubility somewhat remains the same. The kinetic constants we derived
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by fitting 4.1 to the Michaelis–Menten(MM) equation 2 is a K M of 6.30 mM(±1.12) and k cat (s-1)
of 8.2 × 10-4 . The kinetic parameters are consistent with the previous chapters .

Figure 4.7.Inhibition of 4.00 mM DTBC oxidation by 10 μM Cu (II)-TTC as a
function of Salicylate (mM) in a pH 7.35 buffered solvent of 1:1 HEPES: MeOH

The primary study which is to simply titrate sodium salicylate(SA) into 10 µM of Cu(II)TTC and monitor the formation of quinone product which is around 400-410 nm region of the
electromagnetic spectrum. Our study suggests it’s a relatively weak inhibition given the initial
titration took mM quantities of SA to inhibit the oxidation to less the half the oxidation rate of 10
μM Cu (II)-TTC and the rate never reaches below this point
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The next set of experiments revealed the inhibition pattern of SA inhibition by titrating
DTBC in the presence of 10 μM Cu (II)-TTC while the concentration SA was fixed at mM
quantities. We kept the 10 μM Cu (II)-TTC concentration because the TTC itself has a very strong
molar absorptivity around the maxima st 360 nm ( 1.99 × 104) which extends till 400-410 nm
region The absorption around 1.2 at the spectrometer to keep the measurement error free because
after that the readings were significantly sporadic.

Figure 4.8. Plot of inverse rate V-1 versus inverse substrate concentration [DTBC]-1 at pH
7.35 in 1:1 MeOH/HEPES(50mM)for the inhibition of catechol oxidation of Cu(II)-TTC
by salicylate . The salicylate concentrations are (●) 0.00 mM, (o) 2.5 mM,(▼) 5.00, (∆)
10 mM
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[Salicylate] mM

KM
(mM)

k cat
(sec-1)

Catalytic Efficiency
(M-1 sec-1)

0

2.84(±0.50)

(2.22 ± 0.11) × 10 -3

0.78

2.50

4.00(±1.80)

(2.04 ± 0.28) × 10 -3

0.51

5.00

4.83(±1.24)

(2.02 ± 0.31) × 10 -3

0.42

10.00

5.88(±1.50)

(1.67 ± 0.23) × 10-3

0.28

Table 4.2. Kinetic parameters for the oxidation of catechol inhibition by salicylate.

1/V0=KM /V max × 1/[S] + 1/V max

Eq.3

K M = k -1 + k cat / k 1

Eq.4

The inhibition pattern sown in Figure 4.4 and our analysis from MM parameters
indicates apparent mixed inhibition with competitive and uncompetitive inhibition.. The
parameters for fitting the Line weaver-Burk plot were determined using Eq. 2(chapter 3) and Eq.
3. The data at Table 4.2 guided us in making this conclusion as apparent KM going up with the
increasing SA concentration, the turnover rate that we termed as k cat keep going down. This almost
doubling the KM with doubling the inhibitor concentration clearly indicates the formation of binary
Cu(II)-TTC-SA complex (EI) complex , resulting in the term K ic , the dissociation constant for the
binary entity. However the uncompetitive pathway would e mean there is competition between the
formation of ES complex and ESI complex which eventually prevents the turnover to product;
thus
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emergence of the term K

iu

which is the dissociation constant for the ternary entity with the ESI

complex. We probed the formation of the binary complex with electron spray ionization MS (ESIMS) and assigned the peak upon titrating 3 equivalents of SA( 30 µM)( Figure 4.12). The solvent
system although in this case if ESI-MS was 50:50 MeOH: Water. We had to carefully use only
HPLC grade water and MeOH to reduce the noise significantly as normal lab grade solvents and
water would cause prohibitively noisy spectrum. This mixed solvent system however is different
from the solvent system we used for our activity study which is mostly buffered 50:50 MeOH:
HEPES (50 mM) at pH 7.35.

V𝑚𝑎𝑥
K𝑀

=

𝑉𝑚𝑎𝑥 =

V𝑚𝑎𝑥 /K𝑀

Eq.5

1+[I]/Kic

𝑉𝑚𝑎𝑥

Eq.6

1+[𝐼]⁄𝐾𝑖𝑢

The competitive inhibition constant k ic , was calculated using eq. 5 where [I] is the concentration
of SA in mM which is 7.50(±1.20 ) mM. As previously observed at Figure 4.4 the inhibition
constant is fairly large compared to the 10 µM Cu(II)-TTC , the fitting of mixed inhibition to the
eq. 6 gave even higher 13.50 (±10) mM

number .Considering the conditions and higher

concentration; the uncompetitive inhibition pattern with Kiu we assume it is likely binding through
its deprotonated carboxylate . The high dissociation constant helps us to rule out SA as a good
inhibitor towards inhibiting oxidation of catechols. Again if we shift our focus to soil environment
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SA could probably provide a viable alternative pathway for the binding and inhibiting of metallOTTCs. Such binding should become more significant in the regions with concentration high
enough, possibly close to vegetation.
The uncompetitive inhibition constant of 13.50 mM however indicates the ternary complex
of Cu(II)-TTC-SA-DTBC . The poor fitting for this set of data indicates that we probably need to
go for higher concentration of SA for a more proper fitting which we could not achieved due to
SA falling out of solution at more than 10 mM concentrations. We however are confident that the
ternary complex is relatively unstable comparing the Cu(II)-TTC-DTBC complex. Even the visual
inspection of the figure 4.4 suggests the equilibrium is more favorable towards competitive type
inhibition However the solubility issue might also indicate the solvent polarity is probably playing
a role by altering the active site access by hydrophobic/hydrophilic interactions.

Figure 4.9. Pathway for competitive and uncompetitive inhibition by inhibitors
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After the inhibition study with SA we ventured into another secondary metabolite in the
plants benzoic acid (BA).. For the study we used as sodium salt (Sodium benzoate) to make sure
that the solubility remains the same with the same salt. Out initial titration of Benzoic acid turned
out to be drastically different from the SA. In case of SA the rate never reached to the level of less
than self-oxidation rate of the DTBC. In our case with 16 mM of BA the rate reached to 2.87 nM
/s for 8 mM of DTBC whereas the self-oxidation rate of 8 mM DTBC is 6.60 nM/s. Even though
the rate reaches below the self-oxidation rate of DTBC at 16 mM BA but the high concentration
of BA required to reach this rate indicates weak inhibition. For the rate to reach half the rate of
oxidation of 8 mM DTBC by 10 uM of Cu(II)-TTC it takes 4 mM of BA which is 400 times the
concentration of the complex( Figure 4.6).

Figure 4.10. Inhibition of 8.00 mM DTBC oxidation by 10 μM Cu (II)-TTC as a function of
[Benzoate] mM in a pH 7.35 buffered solvent of 1:1 HEPES: MeOH
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Table 4.3. Kinetic parameters for the oxidation of catechol inhibition by Benzoic acid

KM(mM)

Catalytic Efficiency
-1 -1
(M s )

-3

8.86(±0.85)

0.28

-3

6.64(±0.70)

0.31

-3

5.50(±0.71)

0.28

[Benzoic
acid](mM)

kcat(s )

0

2.52 × 10

2.00

2.05× 10

4.00

1.55 × 10

-1

Figure 4.11. Plot of rate ( mM/s)versus substrate concentration [DTBC] mM
at pH 7.35 for the inhibition of DTBC oxidation of Cu(II)-TTC by benzoate .
The benzoate concentrations are ●( 0.00 mM), (o)2 mM,(▼) 4 mM.
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The inhibition pattern of BA was investigated by means of the Michaelis-Menten kinetics
toward DTBC oxidation by 10 µM Cu(II)-TTC at certain fixed concentrations of BA (Figure 4.8
). In this way we tried to figure out in which manner the BA is inhibiting DTBC turning over to
DTBQ( the quinone derivative). Just like previous study with BA we kept the complex
concentration the same to minimize the measurement error and preventing the readings from
reaching the instrumental limit.
The inhibition pattern from Table 4.2 reveals apparent mixed inhibition with competitive
and uncompetitive inhibition. Our data clearly shows the decrease of KM and k

cat

( thus V

max)

with the increasing concentration of BA. This increase in apparent affinity of the enzyme for the
substrate justifies our assumption that the inhibitor BA in our case is favoring to bind to the ES
complex and preventing the turn over to the quinone product thus decreasing the k cat . Predictably
the decreasing V

max

confirms our conclusion that this mixed inhibition more closely mimics

uncompetitive type inhibition. The k iu for this inhibition fitting turned out to be 3.43 mM(±0.70).
The third choice as an inhibitor was bacitracin which is also known to bind to Cu(II) from
our previous study 72. The inhibition pattern for bacitracin tpward DTBC oxidation is drastically
different from the SA and BA study. The inhibition from direct titration of bacitracin (BC) into
the oxidation reaction of DTBC by 10 µM Cu (II)-TTC indicates bacitracin as a strong inhibitor.
The rates almost immediately drops to the self-oxidation rate of DTBC after adding stoichiometric
amount of BC( 4 µM). From the initial titration we assumed that BC is probably complexing with
Cu(II)-TTC-DTBC complex and preventing it from turning over to the quinone product. So our
next step was to analyze the pattern of inhibition and for that we just followed our previous
protocols and derived the kinetic constants for different concentrations of BC . The constants are
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listed in Table 4.5. From the data it is evident that the V max remains almost the same throughout
the experiment set (k cat ) while the KM increased indicating apparent affinity of the substrate to the
binding site is decreased.. Generally in competitive inhibition the inhibitors ( BC) bind to the same
site as the substrate but the same site binding is not a requirement for other inhibition patterns. The
competitive inhibition constant was calculated by fitting the data into eq. 5 and it is 14.5 µM (±4.3).
Given this low dissociation constant BC can have bigger role in the interaction of secondary
metabolites which is a matter to be studied by its own.

Figure 4.12. Inhibition of 12.00 mM DTBC oxidation by 10 μM Cu (II)-TTC as a
function of [Bacitracin] µM in a pH 7.35 buffered solution of 1:1 HEPES: MeOH
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Figure 4.13. Plot of rate V( mM/s)versus substrate concentration [DTBC]
mM at pH 7.35 for the inhibition of DTBC oxidation by Cu(II)-TTC by
Bacitracin . The bacitracin concentrations are (■) 0, (●)5 µM,(o)10 µM,(▼)
15 µM

Table 4.4. Kinetic parameters for the oxidation of catechol inhibition by Bacitracin

[Bacitracin](µM)

kcat

KM(mM)

-1

(s )

Catalytic Efficiency
-1 -1

(M s )

-4

2.52(±0.66)

0.24

-4

2.94(±0.18)

0.23

-4

3.70(±0.70)

0.17

-4

4.10(±1.08)

0.13

0

6.10 × 10

5

6.72× 10

10

6.15 × 10

15

5.30× 10
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Oxidation in the Presence of H2O2: As part of the pathway shown in figure 3.12,
H2O2 can enable the Cu(II) center to perform redox catalysis in an alternative pathway different
from O2. H2O2 availability in the environment is quite common. It can be a redox reaction
byproduct or even in rainwater{Tanner, 1998 #135} in as high as 40 µM quantity. MichaelisMenten kinetic measurement of the rate of oxidation of 4 mM DTBC by 20 µM Cu(II)-TTC as a
function of [H2O2] afford KM = 13.5 ± 3.70 mM and k

cat

= 99.6 × 10-4 s−1 ( Table 3.2) which is

almost 4 times higher than by DTBC itself. Since H2O2 is a stronger oxidation agent than aerobic
O2 in the oxidation reaction, it is thus important to reveal whether or not various inhibitors can
also successfully inhibit substrate oxidation by Cu(II)-TTC in the presence of H2O2 and also
inhibition direct again the binding of H2O2 to the metal center. The results from such studies are

Figure 4.14.Inhibition of 8.00 mM DTBC oxidation by 10 μM Cu (II)-TTC as a
function of Salicylate in a pH 7.35 buffered solvent of 1:1 HEPES: MeOH in the
presence of 50 mM H2O2
presented below.
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[Salicylate] mM

KM
(mM)

k cat
(sec-1)

Catalytic Efficiency
(M-1 sec-1)

0

21.80(±3.12)

3.15 × 10 -3

0.14

4.00

35.07(±7.69)

2.33 × 10 -3

0.07

16.00

26.28(±4.40)

1.54 × 10 -3

0.06

Table 4.5. Kinetic parameters for the oxidation of catechol inhibition by salicylate in the
presence of H2O2

Figure 4.15: Plot of rate of DTBC oxidation (8 mM) ( mM/S) versus [H2O2] mM
at pH 7.35 catalyzed by Cu(II)-TTC in 1:1 MeOH;HEPES(100mM) at 25 °C with
(●) 0 mM , (o) 4 mM , (▼)16 mM salicylate

Our initial titration of SA against 8 mM DTBC in the presence of 50 mM H2O2 revealed a very
gradual inhibition of oxidation but the just like the aerobic oxidation inhibition the rate never
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reached zero. We The kinetic constants from fitting the data into eq. 2 with different concentrations
of SA ( Figure 4.7) are shown in Table 4.5, with KM going up and Vmax going down ( kcat
decreasing) with increasing amounts of SA which indicate a mixed inhibition pattern. The ESIMS data( Figure 4.12) confirmed the binding of SA to Cu-TTC with 3 equivalents of SA at µM
level, even though the solvent system being different( 50:50 - MeOH: Water) might be a factor to
be considered. The inhibition constants for SA inhibition in the presence of H2O2 are Kic = 4mM(
±0.36) and Kiu = 14.60_( ±2.62) mM which indicates a mixed inhibition pattern which more
competitive in nature.
In case where the inhibitor would favor binding to the ES complex and mimicking
uncompetitive binding we would expect the KM to decrease which did not happen in this case. The
inhibitor is following a mixed inhibition pattern which is more competitive in nature with a
propensity to bind to Cu(II)-TTC complex rather than the [Cu-TTG]–DTBH complex. These
results indicate that salicylate and benzoate can still successfully compete with substrate binding
to the redox-active metal center in Cu-TTC in the presence of the more reactive H2O2.
The specific inhibition activity of BA toward H2O2 in DTBC oxidation catalyzed by Cu(II)TTC also follows a similar pattern as that of SA with K

M

going up and k cat going down with

increasing amount of BA, showing a mixed inhibition pattern. From which the two inhibition
constants can be obtained as Kic = 5mM( ±0.45) and Kiu = _11.20_( ±1.22) mM .We hereby
conclude that BA in the presence of peroxide follows a mixed inhibition pattern toward Cu-TTCcatalyzed catechol oxidation where the BA prefers binding to the Cu(II)-TTC complex than the
Cu)II)-TTC-DTBC complex which is also confirmed by the ESI-MS results discussed in the last
section.
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KM(mM)

Catalytic Efficiency
-1 -1
(M S )

-3

26.3(±04.36)

0.10

-3

28.11(±7.74)

0.06

-3

32.4(±5.48)

0.03

[Benzoic acid]
(mM)

kcat(S-1)

0

2.58 × 10

12.00

1.60 × 10

16.00

0.98 × 10

Table 4.6. Kinetic parameters for the oxidation of DTBC inhibition by Benzoic acid with H2O2

Figure 4.16. Plot of rate V( mM/s)versus substrate concentration
[H2O2] mM at pH 7.35 for the inhibition of DTBC oxidation by
Cu(II)-TTC by benzoate . The benzoate concentrations are ●( 0.00
mM), (o)12 mM,(▼) 16 mM.
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646.708

+

[Cu(II)-Tetracycline +Salicylate] binary
complex

Figure 4.17. ESI-MS spectrum of the binary complex of [Cu-TTC]-Salicylate in
MeOH/H2O (50/50) solution

322.54

+ 2+

[Cu(II)-Tetracycline +Benzoate+H2O+2H ]

Figure 4. 18.. ESI-MS spectrum of binary complex of [Cu(II)-TTC]-Benzoate in
MeOH/H2O (50/50) solution
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Figure 4.19. ESI-MS spectrum of binary complex of [Cu(II)-TTC]-Bacitracin in a MeOH/H2O
(50/50) solution

Materials and Methods:
All the reagents and solvents were purchased either from sigma Aldrich or Fisher
scientific. The solvents were all HPLC grade and water was from Millipore water system with
conductivity ~18-20µS.
Stock solution of TTC were prepared in DMSO, the HEPES buffer was prepared in Millipore
water by keeping the pH of 7.35±0.05. The 50:50 MeOH: HEPES solution was prepared by
mixing equal volume of HPLC grade MeOH with the 100 mM HEPES buffer. The buffer was
however pH adjusted before we added the MeOH. Catechol and DTBC (3, 5-Di-tert-butylcatechol
) were prepared in MeOH freshly and never kept more than 24 hours. The MBTH(3-Methyl-2-
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benzothiazolinone hydrazine) were dissolved in Millipore water. The Molar absorptivity of
oxidized products of Catechol/MBTH , dopamine MBTH and DTBC were used to solve the rates(
ɛ= 32500 M-1 cm -1 for catechol MBTH, 27200 M-1 cm -1 for dopamine/MBTH, 1910 M-1 cm -1 for
DTBC at 410 nm using Carry 50 Bio UV-Visible spectrometer. The temperature was kept at 25
°C using a submersible water pump.
Mass spectra were recorded on a Micromass Quattro II triple quadrupole mass spectrometer
using electrospray ionization with a MassLynx operating system.
For fitting data into equations we used Sigmaplot 12.0 and GraphPad Prism 9 . All the traces were
run multiple times. The pH meter was titrated every day using Corning pH buffer. The
spectrometer was blanked with either solvents or the buffer systems. The TTc concentration was
accurately measured by taking the absorption at 360 nm and using the ɛ= 1.99 × 104 M-1 cm

-1

.

Metallic salts were calibrated against AAS standard solutions from Fisher Scientific. The micro
pipettes were regularly calibrated against high purity water from Millipore water systems.
Conclusion:
In this study we investigated the inhibition activities of SA, BA and BC against Cu(II)TTC catalyzed oxidation of DTBC . Our conclusion based on the experimental data suggests that
both SA and BA are weak inhibitors toward Cu(II)-TTC-mediated oxidation of DTBC, following
a mixed inhibition pattern. SA however exhibits more uncompetitive type by showing mixed
inhibition pattern while BA exhibits more competitive type by showing mixed inhibition pattern
too. The distinct inhibition type suggest SA prefers binding to the Cu(II)-TTC-DTBC complex
while BA prioritize binding to the Cu(II)-TTC itself. The high kic and kiu values however suggests
bot BA and SA are weak inhibitors against Cu(II)-TTC mediated oxidation. In the presence of
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H2O2, the inhibition patterns become more competitive for SA and BA, indicating a role played by
ternary Cu(II)-TTC-O2 – complex. BC shows strong inhibition against Cu(II)-TTC with kic in the
low µM region; making it a strong inhibitor against Cu(II)-TTC mediated oxidation.
References:
1.

Güell, M.; Siegbahn, P. E., Theoretical study of the catalytic mechanism of catechol

oxidase. JBIC Journal of Biological Inorganic Chemistry 2007, 12 (8), 1251-1264.
2.

Pulicharla, R.; Hegde, K.; Brar, S. K.; Surampalli, R. Y., Tetracyclines metal

complexation: significance and fate of mutual existence in the environment. Environmental
Pollution 2017, 221, 1-14.
3.

Lesch, J. E., The first miracle drugs: how the sulfa drugs transformed medicine. Oxford

University Press, USA: 2007.
4.

Finlay, M.; Marcus, A. I., “Consumer Terroists”: Battles over Agricultural Antibiotics in

the United States and Western Europe. Agricultural History 2016, 90 (2), 146-172.
5.

Finlay, M. R., Hogs, antibiotics, and the industrial environments of postwar agriculture.

Industrializing organisms: introducing evolutionary history 2004, 237-260.
6.

Bud, R., Penicillin: triumph and tragedy. Oxford University Press on Demand: 2007.

7.

Kirchhelle, C., Pyrrhic progress: the history of antibiotics in Anglo-American food

production. 2020.
8.

Jones, M.; Carpenter, A., The Creeping Impact of Humans on Wildlife: Antibiotic

Resistant Genes and the Dysbiosis of Mantled Howler Monkeys. 2021.

115

9.

Gelband, H.; Miller-Petrie, M.; Pant, S.; Gandra, S.; Levinson, J.; Barter, D.; White,

A.; Laxminarayan, R., The state of the world’s antibiotics. Washington DC: Center for Disease
Dynamics. Economics & Policy 2015.
10.

Li, Y.-W.; Wu, X.-L.; Mo, C.-H.; Tai, Y.-P.; Huang, X.-P.; Xiang, L., Investigation of

sulfonamide, tetracycline, and quinolone antibiotics in vegetable farmland soil in the Pearl River
Delta area, southern China. Journal of agricultural and food chemistry 2011, 59 (13), 72687276.
11.
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Chapter Five: Short Metallopeptide and Metallopeptoid Catalysis of Catechol Oxidation:
Background:
Metallopeptides and Peptoids: Metal ions in general plays a significant role in biological
systems by being active centers and cofactors for catalysis of reactions such as redox and acidbase. They exert this influence by binding and transforming organic molecules 4. Many model
systems that are able to coordinate with metal ions have been known and well-studied for decades.
Short peptides have been used to mimic metalloenzymes

6,7, 8,9

and metalloproteins

10,11,9,12.

The

focus in this is mainly on interaction with amino acids and different peptides mimicking biological
systems. It’s a common knowledge in chemistry that amino acids can bind with each other via
peptide bonds in almost unlimited number of sequences and some of these sequences have the
ability to interact with metal ions depending on the structure and sequences. Peptides can interact
with metals with either the backbone or the side chains.

Figure -5.1.A simple tetra-peptide with different ligating site in red( terminal
amino and carboxylate groups), green (side chain donors) and ( amide) blue3
Figure 5.1 shows a very simple peptide with 4 residues having more than 10 ligating sites.
Transition metals like copper are essentially Lewis acids having empty orbitals which can accept
electrons from Lewis bases like some amino acids at deprotonation conditions. Amino acid side
chains like histidine’s imidazole moiety, phenol in the tyrosine, methionine thioether moiety and
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carboxylates on the glutamic acid and aspartic acids (Figure 5.3) are perfect metal coordination
sites

. Copper, zinc, iron

4, 13, 13

containing metalloenzymes play very significant roles in numerous

systems that ranges from ferrying electrons to catalyzing reactions to DNA transcription ,
signaling, hydrolysis etc 13 .
Peptoids on the other hand are poly-N-subtitututed glycines which are another class of
peptide-mimetic compounds. These essentially poly-N_substituted peptides have been classified
as “peptoids” by Reyna Simon et al 14(1992)

15 ,16

. The

one key advantage of peptoids is that they

have superior biostability due to their invisibility from natural proteolytic enzymes recognition. 16,
16, 14, 15

. The building structure of peptoids are peptide like except the sidechains are on the backbone

nitrogen rather than the α- carbon. Due to their freely rotating β-carbon they can form complex
secondary structure. Because of this structure peptoids can have the same number of side chains
and same back bone as the α-peptides except for the structural modification. A former PhD student
in the group Christian Tang, Ph.D. worked on this parallel study with peptoid of the same sequence
as the peptide both the studies have been compiled here for the comparison. The number of study
on peptoids as metalloenzyme mimic is very rare, most of the works are on protein mimics. The
interaction of metal peptoid have been studied and reported in the last couple of years 17,18, 19. There
are some works done peptoid based metallo-porphyrins

20, 21, 22, 22.

. Another study have studied

peptoids as inhibitors against metal-centered neurodegenerative diseases like Alzheimer’s
disease(AD), Parkinson’s disease(PD) 23 .
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γ-AA-FHFH (Peptoid)

Figure 5.2: Ac-FHFH (Peptide)(Bottom) and Peptoid(Top)
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Our choice of transition metal, copper (Cu) is ubiquitous in various proteins due to its
very efficient electron transfer ability from Cu (I) to Cu (II). This efficient transfer of electrons is
very handy in assisting the different biological redox functions. The different Cu-containing
enzymes that are related to this study are those which can bind and activate O2, including
monooxygenase, dioxygenase and oxidases. Monooxygenase can incorporate one oxygen atom of
O2 into the substrate while reducing the other oxygen into water and dioxygenase can incorporate
both O atoms of O2 into organic substrates. The Oxidase however reduce both of the oxygen atoms
into water 24. Cu can exist in three different oxidation states Cu(I), Cu(II) and Cu(III), of which
Cu(I) is the least discussed in coordination chemistry 25 . The Cu (II) however has a configuration
of d 9; thus making it paramagnetic by having one unpaired electron. Cu3+ is rare and out of the
scope of our discussion. Cu(I) has a tendency to form three and four-coordinated complexes which
are rather stable having coordination geometries of mostly octahedral, trigonal pyramidal and
trigonal tetrahedral type 5. The Cu (II) is however interesting being paramagnetic it’s a strong
Lewis acid and can adopt numerous coordination geometry. Common geometries are square
planar, trigonal bipyramidal, square pyramidal and most commonly octahedral 5. The octahedral
geometry of Cu(II) is often associated with Jahn-Teller distortion due to the uneven electron
distribution in the doubly degenerate eg orbitals which causes the octahedral geometry to distort
by elongation or contraction along the dz2 orbital to gain stability24,25, 25,4 . The Cu (II) is however
interesting being paramagnetic it’s a strong Lewis acid and can adopt numerous coordination
geometry. Common geometries are square planar, trigonal bipyramidal, square pyramidal and
most commonly octahedral 5. The octahedral geometry of Cu(II) is often associated with JahnTeller distortion due to the uneven electron distribution in the doubly degenerate eg orbitals which
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causes the octahedral geometry to distort by elongation or contraction along the dz2 orbital to gain
stability24,25, 25,4 .

Figure 5.3: Amino acids with a side chain available for metal coordination

Researchers have long been focused on investigating the roles of metals in proteins by
using peptide based transition metal complexes as model systems24. The number of studies done
on oxidase study of Cu(II)-peptide complexes are relatively rare

26 , 27 ,28 ,29, 30, 7 ,8 31

these are done on superoxide dismutase (SOD) mimicking peptides

. Majority of

6 , 32 ,33 , 34 ,35

. Oxidase

mimicking peptoids are even rarer which have been discussed before. My research presented in
this chapter is about the structure and activity of the Cu(II) complex of a simple peptide which is
compared with a previously studied Cu(II) complex of an analogous peptoid( Figure 5.2), both
mimicking the histidine-rich structure in the active site of catechol oxidase.
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The sequence of the peptide is acylated Ac-FHFH with potential bidentate binding two His
residues, and an analogous sequence in a peptoid for comparison. Their binding with Co (II) was
investigated, and the oxidative activities of their Cu(II) complexes were also investigated through
the reaction of oxidation of catechol and derivatives to the corresponding benzoquinones in the
presence of O2 and H2O2. The NMR binding study is the work done by Darrell Cole Cerrato, Ph.D.
while the reaction study was done by me and Christian Tang, PhD
Results and Discussion:
The structure of both the peptide and peptoid at figure 5.2 both sequences contain two
histidine and two phenylalanine residues. The two histidines are intentionally built there for
possible metal coordination via the imidazole moiety. The presence of phenylalanine is for
providing stability in the complex formation acting an anchor.

In the case of the simple

oligopeptides like this, the terminal amino group is the most common anchor as in our case is
phenylalanine and its coordination to the metal ion is the governing factor during complex
formation 3. As shown in the Figure 5.4 and 5.5 the simple titration1 of Cu (II) into γ-AA-FHFH
results in distinct peak formation at 342 nm which eventually reach saturation indicating binding
of the Cu (II) into the ligand in the metal to ligand stoichiometry of 1:2. Our study with Ac-FHFH
resulted in the same fashion indicating 1:2 Metal: to ligand stoichiometry.
For investigating the binding further a former PhD student Dr. Darrel Cerrato conducted
some 1H NMR experiment to look at coordination sites. Paramagnetic NMR has been a great tool
for elucidating coordination environment upon binding. In his work Co (II) was used a probe for
binding with Cu (II). The reason for picking Co(II) as a probe lies in its fast electronic spin
relaxation that renders very characteristic hyperfine shifted signals attributable to ligand nuclei
upon binding 36, 37, 38, 38, 37,39.
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Figure 5.4:Cu(II) titration to 0.146 mM γ-AA-FHFH in MeOH at 25 ° C 1
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Figure 5.5: Plot of Absorbance vs Cu(II) equivalents at 346 nm from Figure 5.4 1
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Figure 5.6 : overlaid spectra for 4 mM Ac-FHFH (top) and γ-AA-FHFH (bottom) and 1
Equivalent of Co2+ 2

. The Figure 5.6 is an overlaid spectra of Ac-FHFH and γ-AA-FHFH in 1 equivalents of Co (II) .
As we look at the spectra we can see two set of signals for Co(II)-FHFH in d4-MeOH with peaks
at 55.2,57.3,66.5 and 70.4 ppm 2 while the Co(II)- γ-AA-FHFH has peaks around 65.8 and 44.6
ppm( bottom spectrum).This spectrum is very similar to MnSOD and azurin paramagnetic spectra
where Co2+ was used instead of Mn and Cu 2+ 39, 39. Usually the ortho protons with reference to the
coordination site on the histidine imidazole ring would have somewhat broad and less intense peak
given they are visible; as sometimes they are barely visible at all.
The meta-protons (referenced to Nδ1H) however produce really prominent peaks which are
the δ2 H and Nε2H in the figure 5.7. Figure 5.6 top spectra has for Ac-FHFH has four prominent
signals at 55.2, 57.3, 66.5 and 70.4 ppm indicating bidentate binding through Nδ1H 2. For the
peptoid (bottom spectra) the two intense signals at 65.8 and 44.6 ppm indicates binding through
Nε2H. In the inset the broad signals at 96 ppm have been postulated to be assigned to the orthoprotons in reference to the Nε2H. The binding through Nε2H have been farther confirmed by
solvent exchange experiment where the disappearance of N-H signals from N-H to N-D exchange
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upon addition of drop of D2O .Dr. Cole postulated the reason of different binding modes between
the

Figure 5.7: Numbering scheme of Histidine for 1H-NMR signal assignment 2

Peptide and peptoid is probably the extra rotation around the CH2 moieties of the peptoid which
makes them more flexible. The effect of solvation was also investigated by adding mixed solvents
into NMR tubes which indicated weakening of the binding between the metal and Nitrogen 2. The
effect was presumably profound in case of the peptide.
As peptoid/peptide-metal reactivity is still mostly unexplored in medicine. So we also
ventured onto investigate the reactivity of the peptoid and peptide. As a model system to study
dioxygen activation in the presence and absence of H2O2 by the pair; peptide and corresponding
peptoid we studied the reaction of oxidation of catechols to corresponding benzoquinones. We
picked 3,5-di-tert-butyl catechol(DTBC) as our model substrate given its superior solubility profile
and availability of comparable data. Even though this chapter summarized the combined study of
both the peptide and peptoid , the peptide study was conducted by me while the corresponding
parallel study with peptoid (γ-AA-FHFH) was done by Christain Tang, PhD 1.
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DTBC oxidation by complexes in methanol
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Figure 5.8 :DTBC oxidation by 5 μM 1:1 Cu(II):γ-AA-FHFH and
1:2 Cu(II):γ-AA-FHFH in MeOH 1

Figure 5.9: DTBC oxidation by 5 μM 1:1(●) Cu (II): Ac-FHFH and
1:2(o) Cu (II):γ-AA-FHFH in MeOH: HEPES(50mM)
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Since from the UV-Vis titration study it was evident that both the peptide and peptoid can bind to
Cu (II) in 1:1 and 1:2 Metal to ligand stoichiometry we prepared both the peptide and peptoid in
MeOH in these two ratios and the study was done paralleling each other. The oxidized quinone
product was monitored at 400 nm over time. The initial DTBC saturation curve with the Ac-FHFH
1:1 and 1:2 complex both showed saturation of the initial reaction with increasing substrate
concentration indicating the formation of catalytically active Cu (II)-Peptide-DTBC ternary adduct
in pre-equilibrium kinetics followed by the rate determining intramolecular redox process (Figure
5.9). the corresponding γ-AA-FHFH study exhibited the same characteristics except the K

m

for

the saturation curves were drastically different .With the peptoid 1:1 complex the K m were almost
1/18th of the corresponding peptide complex, the 1:2 complex the trend remains almost the same
at 1/16th( Table 5.1)

Eq. 5.1
Km =
V0=

𝒌−𝟏 +𝒌𝒄𝒂𝒕

Eq.5.2

𝒌𝟏

V
[DTBC]
max
K +[DTBC]
m

Eq.5.3

To calculate Km the data of Figure 5.9 was fitted to Eq. 5.3. Evaluation of this saturation curve by
this non-linear least-square method resulted in the other Michalis-Menten( MM) parameters k cat
and k cat / Km (Table 5.1).K m is the apparent dissociation complex of the Cu(II)-Ac-FHFH-DTBC
complex which can be described as Eq. 5.2. The overall enzyme mimicking behavior is quite often
defined by the ratio k cat / Km which is also referred as catalytic efficiency (CE). The CE values of
the 1:1, 1:2 complexes of the peptide complexes are very low compared to other similar peptides
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reported in the literature 6, 8, 9, 32, 33 . But when we switch to the peptoids the CE value jumps almost
66 times in case of the 1:1 complex, for the 1:2 complex it jumps to almost 5 times indicating
significantly better Catechol oxidase mimicking behavior for the peptoid complexes. The d 9, Cu
(II) configuration explains this behavior. With the d 9 configuration the Cu (II) has six coordination
sites in total which leave room for other ligands to bind. While in the 1:1 complex one γ-peptoid
binds to one Cu (II) center in bidentate manner through the Histidine εN’s. The substrate DTBC
binds through the other two coordination sites leaving 2 sites for redox cycle. In case of the 1:2
complex all the coordination sites

get occupied leaving no site left for the O2 binding, thus

dropping the CE significantly. In case of peptide the CE staying almost the same poses the question
about the second ligand binding to the metal center

Figure 5.10:H2O2 saturation plot of DTBC oxidation by 5 μM 1:1(●) Cu (II): Ac-FHFH and
1:2(o) Cu (II): Ac-FHFH in MeOH: HEPES (50mM) at 25 ° C
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Table 5.1: Catalytic parameter of DTBC oxidation by 5 μM 1:1 and 1:2 Cu (II): γ-AA-FHFH/ Cu
(II)-Ac-FHFH with and without the presence of H2O2 in methanol / MeOH: HEPES(50 mM) at
25 ºC. In collaboration on this project with Christian Tang, Ph.D.1.
Complex/ Substrate
Cu(II)-Ac-FHFH(1:1)/ DTBC
Cu(II)-Ac-FHFH(1:2)/ DTBC
Cu(II)-Ac-FHFH(1:1)/ H2O2
Cu(II)-Ac-FHFH(1:2)/ H2O2
1
Cu: γ-AA-FHFH(1:1)/ DTBC
1
Cu: γ-AAFHFH(1:2)/DTBC
1
Cu: γ-AAFHFH(1:1)/ H2O2
1
Cu: γ-AAFHFH(1:2)/ H2O2

V max (mM/S)

k cat (s-1)

K m (mM)

k cat / K m(M-1s-1)

1.64(±0.18) × 10-4

3.21 × 10-4

3.10(±0.84)

1.06

1.97(±0.20) × 10-4

3.94× 10-4

3.40(±0.82)

1.16

4.53(±0.38) × 10-4

90.7 × 10-4

1.50(±0.04)

60.45

6.00(±0.08) × 10-4

120× 10-4

2.0(±0.10)

60

(0.62±0.02)×10–4

1.20× 10-2

0.17(±0.02)

70

(5.35±0.01)×10–6

0.11× 10-2

0.21(±0.02)

5

(2.00±0.06)×10–4

4.00× 10-2

0.042(±0.01)

940

(2.00±0.1)×10–4

4.00× 10-2

0.029(±0.01)

1380

In the proposed mechanism of catechol oxidation by Cu (II)-Ac-FHFH and Cu (II): γ-AAFHFH complex there are possibly two alternate pathways. The first pathway starts with ( Figure
3.12) DTBC binding to the Cu(II) center in one of the several ways reported , then releasing the
semiquinone product reducing the Cu(II) into Cu(I), thus opening up the Cu(I) center for the O2
binding, subsequently forming the intermediate and continue redox cycle( path c, Figure 3.12).
In the second pathway however H2O2 comes into play. Peroxide can directly bind to the Cu
(II) center, forming the highly reactive species through side-on binding (η2) and continue through
the redox cycle.. The 3 possible binding modes of H2O2 to Cu(II) centers are Cu(II)-superoxo(-O2), Cu(III)-Peroxo(-O22-) and Cu(II)-hydroperoxo(-OOH) 5. The structures of these three complexes
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make the possible binding mode obvious (Cu(III)-Peroxo(-O22-) and Cu(II)-hydroperoxo(-OOH))
considering steric hindrance ( Figure 5.11)

Figure 5.11: Binding modes of Cu/O2( Top), Binding modes of O2 binding to Di-copper
center and distances in Å(Bottom) 1 , 5

141

Figure 5.12 : DTBC oxidation by 5 μM of 1:1 with Cu(II):γ-AA-FHFH complex in the
presence 0 (●), 0.5( o),2(▼),4(∆),(■)8 mm of H2O2 in methanol at 25 ºC.1
As of now both Ac-FHFH and γ-AA-FHFH have shown to be able to mimic catechol
oxidase with the peptoid being significantly efficient (table 5.1). H2O2 presence usually enhances
the oxidation rate due to formation of reactive species. We investigated the Ac-FHFH’s ability to
perform peroxidation in a fixed concentration of DTBC and varying concentration of peroxide.
The peroxide saturation plot exhibited pre-equilibrium enzyme -like kinetics confirming
peroxidation. As a natural next step we did the same study with 1:2 Metal to Ligand complex. The
resultant trace (Figure 5.10) clearly showed Michaelis-Menten like kinetics enabling us to
calculate the kinetic constant Km, k cat and CE. The significant enhancement in CE (more than 50
times) (Table 5.1) however suggested that the presence of peroxide enhancing the ternary adduct
to turn over to the product. The parallel study with the peptoid proved to be following the same
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trend, the H2O2 enhanced the CE to bump up almost more than 13 times (1:1 complex), 272 times
(1:2 complex) exhibiting excellent catalysis. Our analysis suggests the peptide Ac-FHFH shows
selectivity towards peroxidation to a lesser extent than the γ-AA-FHFH in case of 1:2 complex.
The selectivity for peroxidation in case of 1:2 complex of the peptoid is significantly higher. In
both the cases the selectivity towards peroxidation for 1:1 complex is evident but less than the 1:2
complex.
Hanes analysis replot: DTBC oxidation by 5 uM 1:1 Cu(II)-AA-FHFH in methanol with varying peroxide concentration
50000
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Figure 5.13: Linear plot of Hanes analysis of DTBC oxidation by 5 μM of 1:1 with Cu(II):γ-AA
FHFH complex in the presence of o (▀),0.5(o),2(▼),4(∆), 8(■) mm of H2O2 in methanol at 25
ºC.1
Now as both the DTBC and Hydrogen peroxide can bind to the Cu(II)-Ac-FHFH complex
through the metal center with/without assiatance and still exhibit Mechaelis-Menten like kinetics
we assumed it’s a bi-substrate system. So as a natural next response we ventured on to Hanes
analysis to investigate how the binding of one substrate effect the other. Figure 5.13 shows
numerous concentrations of H2O2 were fixed for each trace while we titrated DTBC against 5 µM
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of Cu(II)-Ac-FHFH 1:1 complex concentration in 50:50 MeOH: HEPES( 50 mM). The 400 nm
peak for the formation of quinone product was monitored to get the rates. The rates were then
plotted against DTBC concentrations (Figure 5.13). The data points were further secondarily
processed to avail a plot of vs [DTBC]/V0 vs [DTBC] (Figure 5.14) and fit to Eq 5.4 for subsequent
Hanes analysis to avail the kinetic parameters present in the equation.

Figure 5.14: DTBC oxidation by 5 μM of 1:1 with Cu(II):Ac-FHFH complex
in the presence 0 (●), 16( o),32(▼),64(▲),(■)128 mm of H2O2 in methanol:
HEPES(50 mm) at 25 ºC.

Eq. 5.4
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Figure 5.15: Linear plot of Hanes analysis of DTBC oxidation by 5 μM
of 1:1 with Cu(II):Ac FHFH complex in the presence of
0(●),16(o),32(▼),64(▲), 200(■) mm of H2O2 in methanol at 25 ºC.

The Eq. 5.4 consists of 3 different kinetic parameters that we are calculating. The KAppDTBC,
KAppH2O2, KintH2O2. The KAppDTBC, KintH2O2 are the apparent dissociation constants for the DTBC and
H2O2 respectively representing the ternary H2O2-DTBC-Cu (II)-L complex. KintH2O2 is the intrinsic
dissociation constant for peroxide. These 3 parameters are collected from the secondary plots of
Figure 5.14 where the slopes and y-intercepts were plotted against H2O2-1 in Figure 5.17 and 5.18.
The three parameters are then calculated from the plots fitting based on Eq. 5.5 and 5.6
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The idea of Hanes analysis is that upon calculating the constants the ratio between the
apparent and intrinsic dissociation constants of the DTBC and H2O2 gives us an idea about how
the subsequent binding of each substrate effects the binding of the other. For the 1:1 complex of
Ac-FHFH the ratio of KAppDTBC / KintDTBC is 8.87 while the same ration for H2O2 is 4.14 indicating
that the binding of both substrate to the Cu(II)-FHFH center were weakened by each other but the
extent of DTBC binding enhancement in the presence of H2O2was almost double than that of the
reverse situation. The same trend persist in case of the γ-AA-FHFH but in this case the extent is
more than triple. (Table 5.2).
For the 1:2 complex however the binding enhancement of the ternary complex is incredibly
drastic in case of both the peptide and peptoid. The massive 41 times enhancement of DTBC
binding in the presence of H2O2 .is rare. The peptide however shows 6 times enhancement which
is relatively less drastic but still significant.(Table 5.3).
The analysis concludes both Cu(II) complexes of Ac-FHFH and γ-AA-FHFH can act as
efficient artificial peroxidase model by the use of H2O2 as the more specific oxidation agent, with
the Cu(II)-γ-AA-FHFH complex to be significantly better
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Hanes analysis replot: y-intercept vs 1/[H2O2]
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Figure 5.16: Secondary plots of the y-intercept vs H2O2-1
from the linear plot from Figure 5.13 1

Hanes analysis replot: slope vs 1/[H2O2]
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Figure 5.17: Secondary plots of the slope vs H2O2-1
from the linear plot from Figure 5.13 1
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Figure 5.18: Secondary plots of the y-intercept vs H2O2-1 from the linear plot
from Figure 5.15

Figure 5.19: Secondary plots of the slope vs H2O2-1 from the linear
plot from Figure 5.15
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Table 5.2: Comparison between (1:1) Cu: γ-AA-FHFH and Ac-FHFH Hanes analysis results of
Kapp and K int of H2O2 and DTBC
Complex (1:1)

Kapp (mM) Kint (mM)

Substrate

Kint / Kapp

Cu: γ-AA-FHFH

DTBC+H2O2

1.62

23.46

14.48

Ac-FHFH

DTBC+H2O2

13.92

57.72

4.14

Cu: γ-AA-FHFH

DTBC

0.004

0.17

42.50

Ac-FHFH

DTBC

0.384

3.40

8.87

Table 5.3: Comparison between (1:2) Cu: γ-AA-FHFH and Ac-FHFH Hanes analysis results of
Kapp and Kint of H2O2 and DTBC
Complex (1:2)

Substrate

Kapp (mM)

Kint (mM)

Kint / Kapp

Cu: γ-AA-FHFH

DTBC+H2O2

1.02

0.77

0.75

Ac-FHFH

DTBC+H2O2

6.35

5.28

0.83

Cu: γ-AA-FHFH

DTBC

0.02

0.63

31.30

Ac-FHFH

DTBC

1.14

5.24

4.59

Conclusion:
I present in this chapter the results about the metal binding capability of a peptide
Ac-FHFH and its oxidation chemistry with and without H2O2 and compare the results with those
of the Cu(II) complexes of γ-AA-FHFH. The study concludes the peptide binds to Cu (II) as both
1:1, 1:2 metal-to-ligand complexes. Both the peptide and peptoid show higher selectivity towards
H2O2, with the peptoid showing much higher selectivity compared to Ac-FHFH. As the field of
peptidomimetics develop over next decades with increasingly automated and sophisticated
synthesis we should be able to develop more methods to build three dimensional complex motifs
which should enable us to investigate even more complex structures mimicking complicated
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systems. As a peroxidase mimics the Cu(II) complexes of the peptide and peptoid presented herein
are definitely viable examples of artificial enzymes.
Material and Methods:
All the reagents and solvents were purchased either from sigma Aldrich or Fisher scientific.
The solvents were all HPLC grade and water was from Millipore water system with conductivity
~18-20µS. The Ac-FHFH and γ-AA-FHFH was synthesized using standard solid-phase synthesis
technique.
Stock solution of Ac-FHFH were prepared in MeOH, the HEPES buffer was prepared in Millipore
water by keeping the pH of 7.35±0.05. The 50:50 MeOH: HEPES solution was prepared by
mixing equal volume of HPLC grade MeOH with the 100 mM HEPES buffer. The buffer was
however pH adjusted before we added the MeOH. Catechol and DTBC (3, 5-Di-tert-butylcatechol
) were prepared in MeOH freshly and never kept more than 24 hours. The Molar absorptivity of
oxidized products of DTBC were used to solve the rates (1900 M-1 cm -1) for DTBC at 410 nm
using Carry 50 Bio UV-Visible spectrometer. The temperature was kept at 25 degree Celsius using
a submersible water pump. Both the Ac-FHFH and γ-AA-FHFH were dissolved in MeOH. We
employed the phenylalanine molar absorptivity at 257 nm ((200 M-1 cm -1) to calculate exact
concentration of the stock solution. For the base of Triethylamine (TEA) was added to the
solutions. CoCl2 was used as cobalt source as a probe for Cu (II).
For fitting data into equations we used Sigma plot 12.0 and Graph Pad Prism 9. All the traces were
run multiple times. The pH meter was titrated every day using Corning pH buffer. The
spectrometer was blanked with either solvents or the buffer systems. Metallic salts were calibrated
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against AAS standard solutions from Fisher Scientific. The micro pipettes were regularly
calibrated against high purity water from Millipore water systems.
The paramagnetic 1H NMR spectrums were acquired with stoichiometric amount of Co (II)
on INOVA 600 MHz NMR spectrometer with triple resonance probe. Deuterated solvents were
used for both the peptide and peptoid (D2O, d3-MeOH, d4-MeOH, and d6-DMSO) based on
experimental design.
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